Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
    November 2022
  1. VENTER F, Sokhela S, Calmy A, Siedner MJ, et al
    Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2022;36:1900-1901.
    >> Share

  2. TARAMASSO L, Di Biagio A, Guaraldi G
    Response to: weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2022;36:1899-1900.
    >> Share

  3. AHLUWALIA AK, Inzaule S, Baggaley RC, Vitoria M, et al
    Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis.
    AIDS. 2022;36:1897-1898.
    >> Share

  4. CARRARO A, Belvisi V, Garattini S, Cacace S, et al
    A case of primary central nervous system lymphoma in advanced naive HIV-infected patient: the role of antiviral agents.
    AIDS. 2022;36:1895-1896.
    >> Share

  5. KOWALSKA JD, Rukhadze N, Sojak L, Bociaga-Jasik M, et al
    Preliminary report on the provision of HIV care to war refugees with HIV who are migrating from Ukraine: data from the ECEE Network Group.
    AIDS. 2022;36:1887-1890.
    >> Share

  6. XIA Q, Edelstein ZR, Blumenthal JS
    Improving HIV preexposure prophylaxis implementation within healthcare settings.
    AIDS. 2022;36:1883-1885.
    >> Share

  7. DUARTE FC, Moura LM, Laranjinha J
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS. 2022;36:1881-1882.
    >> Share

  8. LAEREMANS T, D'haese S, Aernout J, Barbe K, et al
    Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH.
    AIDS. 2022;36:1761-1768.
    >> Share

  9. LUMU I, Musaazi J, Castelnuovo B
    Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting.
    AIDS. 2022;36:1791-1800.
    >> Share

    October 2022
  10. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
    AIDS. 2022;36:1747-1748.
    >> Share

    Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV.
    AIDS. 2022;36:1746-1747.
    >> Share

  12. JONAS KJ, Parczewski M, van de Vijver D
    The war refugees from Ukraine: an HIV epidemic is fleeing as well.
    AIDS. 2022;36:1745-1746.
    >> Share

  13. LANGLIE J, Mittal R, Bencie NB, Sharma U, et al
    Unraveling the mechanisms of HIV-induced hearing loss.
    AIDS. 2022;36:1737-1740.
    >> Share

    The right balance between weight gain and insulin sensitivity with integrase inhibitors.
    AIDS. 2022;36:1735-1736.
    >> Share

  15. MILIC J, Guaraldi G
    Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of life.
    AIDS. 2022;36:1731-1733.
    >> Share

    September 2022
  16. HAGENIMANA M, Kodan AE, George N, Businge L, et al
    Cancer in patients with and without HIV infection in the national cancer registry of Rwanda.
    AIDS. 2022 Sep 28. pii: 00002030-990000000-00120.
    >> Share

  17. SATISH S, Bravo L, McAllister A, Teitelman A, et al
    Provision of HIV pre-exposure prophylaxis to female patients seeking family planning services in the United States.
    AIDS. 2022 Sep 22. pii: 00002030-990000000-00119.
    >> Share

  18. LUBEGA J, Kim TO, Airewele G, Grimes A, et al
    Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on anti-retrovirus therapy.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00116.
    >> Share

  19. JOVANOVIC L, Siljic M, Cirkovic V, Salemovic D, et al
    HIV-1 subtype B spread through cross-border clusters in the balkans: a molecular analysis in view of incidence trends.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00115.
    >> Share

  20. RASMUSSEN LD, Cowan S, Gerstoft J, Kronborg G, et al
    Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00118.
    >> Share

  21. AYTON S, Schwitters A, Mantell JE, Nuwagaba-Biribonwoha H, et al
    Male partner age, viral load, and HIV infection in adolescent girls and young women: Evidence from eight sub-Saharan African countries.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00117.
    >> Share

  22. YOUNGPAIROJ AS, Vanderford TH, Reed MS, Granade TC, et al
    A monoclonal antibody for the detection of the antiretroviral drug emtricitabine.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00092.
    >> Share

  23. MYER L, Odayar J, Malaba TR, Allerton J, et al
    Improved virologic outcomes in postpartum women living with HIV referred to differentiated models of care: a randomised controlled trial.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00113.
    >> Share

  24. MORAN CA, Oliver NT, Szabo B, Collins LF, et al
    The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00112.
    >> Share

  25. KENG LD, Winston A, Sabin CA
    The global burden of cognitive impairment in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00110.
    >> Share

  26. SEN S, An H, Oakes J, Eron J, et al
    Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00109.
    >> Share

  27. STONE J, Fraser H, Walker JG, Mafirakureva N, et al
    Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00111.
    >> Share

  28. KIDMAN R, Breton E, Behrman J, Kohler HP, et al
    A prospective study on adverse childhood experiences and HIV-related risk among adolescents in Malawi.
    AIDS. 2022 Sep 12. pii: 00002030-990000000-00108.
    >> Share

  29. PHIPPS W, Adams SV, Mooka P, Kafeero J, et al
    A prospective study of HIV-associated and hiv-negative kaposi sarcoma in Uganda: identifying factors associated with poor outcomes.
    AIDS. 2022 Sep 5. pii: 00002030-990000000-00107.
    >> Share

  30. KOBBE R, Schulze-Sturm U, Kurnaz P, Rau C, et al
    Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants.
    AIDS. 2022;36:1613-1615.
    >> Share

  31. LONGHITANO A, Woolley I, Upjohn L, Korman T, et al
    New diagnosis of HIV with Cryptococcus neoformans infection presenting as a pleural syndrome.
    AIDS. 2022;36:1611-1613.
    >> Share

  32. SATTA S, Hugo C, Sharma M, Rezek V, et al
    Mitoquinone mesylate attenuates brain inflammation in humanized mouse model of chronic HIV infection.
    AIDS. 2022;36:1609-1611.
    >> Share

  33. LONDERO A, Fusi M, Cinausero M, Tascini C, et al
    Effects of the androgen receptor inhibitor enzalutamide on the pharmacokinetics of dolutegravir and tenofovir: a case report.
    AIDS. 2022;36:1603-1605.
    >> Share

    HIV accelerates clonal hematopoiesis and cardiovascular aging.
    AIDS. 2022;36:1599-1601.
    >> Share

  35. CONWAY B, Brenner BG
    Can simplified antiretroviral drug combination therapies resist resistance?
    AIDS. 2022;36:1597-1598.
    >> Share

  36. TITANJI BK, Wang Z, Chen J, Hui Q, et al
    Soluble CD14-associated DNA methylation sites predict mortality among men with HIV infection.
    AIDS. 2022;36:1563-1571.
    >> Share

  37. ETZKORN LH, Liu F, Urbanek JK, Heravi AS, et al
    Patterns of objectively measured physical activity differ between men living with and without HIV.
    AIDS. 2022;36:1553-1562.
    >> Share

  38. SAVINELLI S, Wrigley Kelly NE, Feeney ER, O'Shea DB, et al
    Obesity in HIV infection: host-pathogen interaction.
    AIDS. 2022;36:1477-1491.
    >> Share

  39. LUBEGA J, Grimes A, Airewele G, Bulsara S, et al
    Risk factors and prognostic significance of anemia in children with hiv infection on anti-retroviral therap.
    AIDS. 2022 Sep 1. pii: 00002030-990000000-00106.
    >> Share

    August 2022
  40. LUCAS J, Lin LY, Paul N, Laumond G, et al
    Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00101.
    >> Share

  41. JASCHINSKI N, Greenberg L, Neesgaard B, Miro JM, et al
    Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00102.
    >> Share

  42. MAJONGA ED, Yindom LM, Hameiri-Bowen D, Mayini J, et al
    Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00100.
    >> Share

  43. THINDWA D, Mwalukomo TS, Msefula J, Jambo KC, et al
    Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.
    AIDS. 2022 Aug 22. pii: 00002030-990000000-00094.
    >> Share

  44. WHITE HA, Baggaley RF, Okhai H, Patel H, et al
    The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent TB infection testing in HIV: cohort study results.
    AIDS. 2022 Aug 19. pii: 00002030-990000000-00096.
    >> Share

  45. FINK DL, Oladele DA, Slack AJ, Odubela O, et al
    A multicentre observational study of HIV, TB and risk of chronic lung disease in urban west Africa.
    AIDS. 2022 Aug 19. pii: 00002030-990000000-00093.
    >> Share

  46. THEERASUWIPAKORN N, Rungpradubvong V, Chattranukulchai P, Siwamogsatham S, et al
    Higher prevalence of QTc interval prolongation among virologically suppressed older people living with HIV.
    AIDS. 2022 Aug 16. pii: 00002030-990000000-00090.
    >> Share

  47. SMITH SA, Murray PM, Amancha PK, Ackerley CG, et al
    T cell activation and B cell interaction signatures in rectal tissues are associated with HIV replication in ex vivo model of infection.
    AIDS. 2022 Aug 16. pii: 00002030-990000000-00091.
    >> Share

  48. HERMANS LE, Ter Heine R, Schuurman R, Tempelman HA, et al
    A randomised study of intensified ART monitoring versus standard-of-care for prevention of drug resistance and ART switch: week 96 results of the ITREMA trial.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00083.
    >> Share

  49. LAKE JE, Wang R, Barrett BW, Bowman E, et al
    Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00081.
    >> Share

  50. DUARTE M, Ma Y, Noworolski SM, Korn N, et al
    Controlled Attenuation Parameter Accurately Detects Liver Steatosis in People Living with HIV.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00082.
    >> Share

  51. JAIN JP, Sheira LA, Frongillo EA, Neilands TB, et al
    Mechanisms linking gender-based violence to worse HIV treatment and care outcomes among women in the United States.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00080.
    >> Share

  52. SPIELER G, Westfall AO, Long DM, Cherrington A, et al
    Trends in diabetes incidence and associated risk factors among people living with HIV in the current treatment era, 2008-2018.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00084.
    >> Share

  53. NUNES MC, Jones S, Ditse Z, da Silva K, et al
    Maternal-foetal transfer of SARS-CoV-2 antibodies among women with and those without HIV infection.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00085.
    >> Share

  54. ALRUBAYYI A, Rowland-Jones S, Peppa D
    Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy.
    AIDS. 2022 Aug 8. pii: 00002030-990000000-00055.
    >> Share

  55. BARNETT SK, Armas-Kolostroubis L, Sension M, Riedel DJ, et al
    Cabotegravir-rilpivirine treatment initiation in a nonvirologically suppressed patient.
    AIDS. 2022;36:1475-1476.
    >> Share

  56. PHILLIPS AN, Sibanda E, Sikwese K, Bansi-Matharu L, et al
    Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa.
    AIDS. 2022;36:1473-1475.
    >> Share

  57. CARRASCO I, Olveira A, Lancharro A, Escosa L, et al
    Fatty liver disease in children living with HIV: a ghostly iceberg.
    AIDS. 2022;36:1471-1472.
    >> Share

  58. SEBASTIANI G, Sebastiani G
    Fatty liver in children with HIV: a clinical iceberg?
    AIDS. 2022;36:1469-1471.
    >> Share

  59. CHAMMARTIN F, Kusejko K, Pasin C, Trkola A, et al
    Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.
    AIDS. 2022;36:1465-1468.
    >> Share

  60. LURAIN K, Uldrick TS, Navarro JT
    Leveraging fine-needle aspiration to improve HIV-associated lymphoma diagnostic capacity in resource-limited settings.
    AIDS. 2022;36:1461-1463.
    >> Share

  61. STAPLETON JT, Bedimo RJ, Guaraldi G
    Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV.
    AIDS. 2022;36:1457-1459.
    >> Share

  62. SCHNEIDER JA, Bouris A
    Ryan White programming that primarily supports clinical care falls short when core people needs are not met: further evidence from the medical monitoring project.
    AIDS. 2022;36:1453-1456.
    >> Share

  63. WOOD BR, Stekler JD
    Baseline HIV genotype drug resistance testing: is it time for more or less?
    AIDS. 2022;36:1449-1451.
    >> Share

    July 2022
  64. FITCH KV, Mccallum SA, Erlandson KM, Overton ET, et al
    Diet in a global cohort of adults with HIV at Low to Moderate Traditional Cardiovascular Disease Risk.
    AIDS. 2022 Jul 27. pii: 00002030-990000000-00079.
    >> Share

  65. YAZDANI K, Salters K, Shen T, Dolguikh K, et al
    A twenty-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00076.
    >> Share

  66. MANN LM, Le Guillou A, Goodreau SM, Marcus JL, et al
    Correlations between community-level HIV preexposure prophylaxis coverage and individual-level sexual behaviors among US men who have sex with men.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00078.
    >> Share

  67. PALA AN, Kempf MC, Konkle-Parker D, Wilson TE, et al
    Intersectional stigmas are associated with lower viral suppression Rates and ART adherence among Women living with HIV.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00075.
    >> Share

  68. LESKO CR, Edwards JK, Hanna DB, Mayor AM, et al
    Longitudinal HIV care outcomes by gender identity in the United States.
    AIDS. 2022 Jul 21. pii: 00002030-990000000-00074.
    >> Share

  69. PELUSO MJ, Spinelli MA, Deveau TM, Forman CA, et al
    Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection.
    AIDS. 2022 Jul 19. pii: 00002030-990000000-00073.
    >> Share

  70. RAI MA, Shi V, Kennedy BD, Whitehead EJ, et al
    Effect of aging on immune cells in male HIV-infected and -uninfected healthy individuals.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00069.
    >> Share

  71. HANSEN ME, Mangusan R, Lurain K, Odeny T, et al
    Characteristics of patients admitted to the intensive care unit with Kaposi sarcoma herpesvirus-associated diseases.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00068.
    >> Share

  72. ROUSSET S, Zenou M, Saunier A, Varenne F, et al
    Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIV: a national survey and literature review.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00072.
    >> Share

  73. FOTSO AS, Johnson C, Vautier A, Kouame KB, et al
    Routine programmatic data show a positive population-level impact of HIV self-testing: the case of Cote d'Ivoire and implications for implementation.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00071.
    >> Share

  74. BANNISTER WP, Mast TC, de Wit S, Gerstoft J, et al
    Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00070.
    >> Share

  75. HUNT M, Mcniff MM, Vincent AE, Sabin C, et al
    Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00060.
    >> Share

  76. HAU TTT, Nishizawa M, Harada S, Phan MH, et al
    Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00066.
    >> Share

  77. GIRARDI E, Caro-Vega Y, Cozzi-Lepri A, Musaazi J, et al
    The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis: a 5-year estimate using real-world data.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00065.
    >> Share

  78. TENG AE, Kennedy KF, Parikh RV, Armstrong EJ, et al
    Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00058.
    >> Share

  79. WEISER B, Shi B, Kemal K, Burger H, et al
    Long-term antiretroviral therapy mitigates mortality and morbidity independent of HIV tropism: 18 years follow-up in a women's cohort.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00061.
    >> Share

  80. MUNGWIRA RG, Laurens MB, Nyangulu W, Divala TH, et al
    High burden of malaria among Malawian adults on antiretroviral therapy after discontinuing prophylaxis.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00064.
    >> Share

  81. ZHU W, Huang YA, Weiner J, Neblett-Fanfair R, et al
    Impact of the COVID-19 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00062.
    >> Share

  82. LI G, Park LS, Lodi S, Logan RW, et al
    Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00063.
    >> Share

  83. TINCATI C, Ficara M, Ferrari F, Augello M, et al
    Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00067.
    >> Share

  84. PANNEER N, Balaji AB, Crim SM, Bosh KA, et al
    Assessing concordance of HIV risk behaviors collected by different surveillance systems.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00059.
    >> Share

  85. NEARY J, Mugo C, Wagner A, Ogweno V, et al
    Caregiver fears and assumptions about child HIV status drive not testing children for HIV.
    AIDS. 2022;36:1323-1325.
    >> Share

  86. BOTTANELLI M, Messina E, Barbera M, Guffanti M, et al
    Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV.
    AIDS. 2022;36:1321-1323.
    >> Share

  87. GIANSERRA L, Dona MG, Giuliani E, Stingone C, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:1319-1320.
    >> Share

  88. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.
    AIDS. 2022;36:1315-1317.
    >> Share

    Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection.
    AIDS. 2022;36:1311-1313.
    >> Share

  90. POLI G, Stapleton JT
    Sex matters... cytokines and disease progression in men and women receiving combination antiretroviral therapy.
    AIDS. 2022;36:1307-1309.
    >> Share

  91. CRUM NF, Ahmad A
    Immunity against measles in people with HIV: the need for more research and surveillance.
    AIDS. 2022;36:1305-1306.
    >> Share

  92. STOVER S, Milloy MJ, Grant C, Fairbairn N, et al
    Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs.
    AIDS. 2022;36:1233-1243.
    >> Share

  93. ZHAO B, Ding H, Song W, Kang M, et al
    Antiretroviral therapy initiation within 7 days and 8 days-30 days post-HIV diagnosis demonstrates similar benefits in resource-limited settings.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00056.
    >> Share

  94. ANTE-TESTARD PA, Hamidouche M, Apouey B, Baggaley R, et al
    Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries: a mediation analysis.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00057.
    >> Share

  95. HUIK K, Hill S, George J, Pau A, et al
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00033.
    >> Share

  96. MICHEL M, Labenz C, Wahl A, Anders M, et al
    Prevalence and risk factors of non-alcoholic steatohepatitis with significant fibrosis in people living with HIV.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00053.
    >> Share

  97. VAKILI S, Paneru B, Guerrier CM, Miller J, et al
    Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing ART.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00054.
    >> Share

  98. MICAN R, Grela AG, Cadinanos J, de Miguel R, et al
    Impact of Pre-Existing Nrti Resistance on the Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00052.
    >> Share

  99. SINGH A, Kumar A, Shankar S, Vashisht R, et al
    Triple trouble: syphilitic neuroretinitis preceding progressive outer retinal necrosis in a HIV-infected man.
    AIDS. 2022;36:1203-1204.
    >> Share

    How much do we need electronic clinical decision support systems to select patients to perform HIV tests in clinical settings?
    AIDS. 2022;36:1201-1202.
    >> Share

    Hypogonadism in HIV infection: time to fine-tune clinical monitoring of persons with HIV?
    AIDS. 2022;36:1197-1199.
    >> Share

  102. WOOD BR, Guthrie BL
    Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial.
    AIDS. 2022;36:1191-1193.
    >> Share

  103. LESKO CR, Mugavero MJ, Shen NM, Fojo AT, et al
    Exploring definitions of retention in care for people living with HIV in the United States in the modern treatment era.
    AIDS. 2022;36:1181-1189.
    >> Share

  104. IGNACIO RAB, Shapiro AE, Nance RM, Whitney BM, et al
    Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.
    AIDS. 2022;36:1095-1103.
    >> Share

  105. SMIT M, Jordans CCE, Reinhard JM, Bramer WM, et al
    Clinical decision support systems to guide healthcare providers on HIV testing.
    AIDS. 2022;36:1083-1093.
    >> Share

  106. COLEMAN H, Fox J, Chilton D
    The risks associated with stopping injectable antiretroviral treatment in women who are trying to conceive: a case series.
    AIDS. 2022;36:1205-1206.
    >> Share

  107. HATCHER AM, Eakle R, Peltz A
    Partner violence as conversation opener for preexposure prophylaxis use among younger women.
    AIDS. 2022;36:1195-1196.
    >> Share

    June 2022
  108. FORD JS, Rouleau S, Voong S, Morgan B, et al
    Universal HIV screening in the emergency department: an interrupted time series analysis.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00040.
    >> Share

  109. CHAISSON LH, Semitala FC, Mwebe S, Katende J, et al
    Transaminitis prevalence among HIV-infected adults eligible for tuberculosis preventive therapy.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00051.
    >> Share

    A role for CD4 helper cells in HIV control and progression.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00045.
    >> Share

  111. PATEL R, Manion MM, Laidlaw E, Wakim P, et al
    Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00042.
    >> Share

  112. SPEARS CE, Taylor BS, Liu AY, Levy SM, et al
    Intersecting epidemics: the impact of COVID-19 on the HIV prevention and care continua in the United States.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00048.
    >> Share

  113. WANG S, Pasca S, Post WS, Langan S, et al
    Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00041.
    >> Share

  114. PATEL EU, Solomon SS, Mcfall AM, Prata Menezes N, et al
    Drug use stigma, antiretroviral therapy use, and HIV viral suppression in a community-based sample of people with HIV who inject drugs.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00050.
    >> Share

  115. WARD AR, Thomas AS, Stevenson EM, Huang SH, et al
    No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00046.
    >> Share

  116. YIN MT, Hoover DR, Shi Q, Tien PC, et al
    Hormone therapy and fracture rates among postmenopausal women: results from the Women's Interagency HIV Study.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00039.
    >> Share

  117. DONADEU L, Tiraboschi JM, Scevola S, Torija A, et al
    Long-lasting adaptive Immune memory specific to SARS-CoV-2 in convalescent COVID-19 Stable People living with HIV.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00049.
    >> Share

  118. FOWLER MG, Hanrahan C, Yende N, Stranix-Chibanda L, et al
    Neurodevelopmental Outcomes of HIV and Anti-retroviral Drug Perinatally Exposed Uninfected Children Aged 3-6 years.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00038.
    >> Share

  119. POURCHER V, Belin L, Soulie C, Rosenzwajg M, et al
    High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00043.
    >> Share

  120. DIETLER D, Farnham A, Lyatuu I, Fink G, et al
    Industrial mining and HIV risk: evidence from 39 mine openings across 16 countries in sub-Saharan Africa.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00047.
    >> Share

  121. CALLEJO A, Molina MDM, Dinares MC, Hernandez-Losa J, et al
    Exploratory study of an oral screening dysplasia program for HIV-infected men who have sex with men.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00044.
    >> Share

  122. SABERI P, Stoner MCD, Ming K, Lisha NE, et al
    The effect of an HIV pre-exposure prophylaxis (PrEP) panel management strategy to increase PrEP prescriptions.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00037.
    >> Share

  123. ELVSTAM O, Marrone G, Engstrom G, Nilsson PM, et al
    Associations between HIV viremia during antiretroviral therapy and cardiovascular disease.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00036.
    >> Share

  124. KAUPPINEN KJ, Aho I, Sutinen J
    Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain.
    AIDS. 2022 Jun 22. pii: 00002030-990000000-00035.
    >> Share

  125. MILIC J, Renzetti S, Ferrari D, Barbieri S, et al
    Relationship between weight gain and insulin resistance in people living with HIV switching to INSTI-based regimens.
    AIDS. 2022 Jun 21. pii: 00002030-990000000-00034.
    >> Share

  126. BUTTERFIELD TR, Hanna DB, Kaplan RC, Xue X, et al
    Elevated CD4+ T cell glucose metabolism in HIV+ women with diabetes mellitus.
    AIDS. 2022 Jun 21. pii: 00002030-990000000-00029.
    >> Share

  127. OKAL JO, Awiti JO, Matheka J, Oluoch-Madiang D, et al
    Unit costs of a community-based girl-centered HIV prevention program: a case study of Determined, Resilient, Empowered, AIDS-Free, Mentored, and Safe program.
    AIDS. 2022;36.
    >> Share

  128. PULERWITZ J, McClair T, Gottert A, Shabangu P, et al
    Effects of men's lifetime adverse events experience on violence, HIV risk, and wellbeing: insights from three countries.
    AIDS. 2022;36.
    >> Share

  129. GOTTERT A, Pulerwitz J, Heck CJ, Shabangu P, et al
    Inroads for HIV prevention among men: findings from mixed methods research in the context of the DREAMS partnership in Southern Africa.
    AIDS. 2022;36.
    >> Share

  130. MATHUR S, Mishra R, Mahapatra B, Heck CJ, et al
    Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women.
    AIDS. 2022;36.
    >> Share

  131. FLOYD S, Mulwa S, Magut F, Gourlay A, et al
    DREAMS impact on HIV status knowledge and sexual risk among cohorts of young women in Kenya and South Africa.
    AIDS. 2022;36.
    >> Share

  132. SAUL J, Cooney C, Hosseini PR, Beamon T, et al
    Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries.
    AIDS. 2022;36.
    >> Share

  133. MTHIYANE N, Baisley K, Chimbindi N, Zuma T, et al
    The association of exposure to DREAMS on sexually acquiring or transmitting HIV amongst adolescent girls and young women living in rural South Africa.
    AIDS. 2022;36.
    >> Share

  134. GOURLAY AJ, Birdthistle I, Mulwa S, Mthiyane NT, et al
    Awareness and uptake of the Determined, Resilient, Empowered, AIDS-free, Mentored and Safe HIV prevention package over time among population-based cohorts of young women in Kenya and South Africa.
    AIDS. 2022;36.
    >> Share

  135. PATEL P, Sato K, Bhandari N, Kanagasabai U, et al
    From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
    AIDS. 2022;36.
    >> Share

  136. SAUL J, Toiv N, Cooney C, Beamon T, et al
    The evolution of DREAMS: using data for continuous program improvement.
    AIDS. 2022;36.
    >> Share

  137. MULLICK S, Cowan FM
    Evaluating the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe programme, what's worked and what more needs to be done?
    AIDS. 2022;36.
    >> Share

  138. OLSSON O, Skogmar S, Tesfaye F, Mulleta D, et al
    Kynurenine/tryptophan ratio for detection of active tuberculosis in adults with HIV prior to antiretroviral therapy.
    AIDS. 2022 Jun 2. pii: 00002030-990000000-00026.
    >> Share

  139. HUNT M, Phillips R, Hardy Y, Owusu DO, et al
    Renal mitochondrial toxicity: effects of thymidine analogues and tenofovir disoproxil fumarate in African people with HIV.
    AIDS. 2022;36:1049-1051.
    >> Share

  140. POST FA, Sinxadi P
    Tenofovir disoproxil and renal mitochondrial toxicity: more studies in Africans are needed.
    AIDS. 2022;36:1047-1048.
    >> Share

  141. MURNANE PM, Gandhi M, Bacchetti P, Getahun M, et al
    Distinct forms of migration and mobility are differentially associated with HIV treatment adherence.
    AIDS. 2022;36:1021-1030.
    >> Share

  142. JIANG W, Ronen K, Osborn L, Drake AL, et al
    Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy.
    AIDS. 2022;36:1007-1019.
    >> Share

  143. KOUAMOU V, Inzaule S, Manasa J
    Weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2022;36:1053-1054.
    >> Share

  144. LE MOING V
    Real-time assessment of adherence to antiretroviral drugs: a moving target.
    AIDS. 2022;36:1045-1046.
    >> Share

    May 2022
  145. JUWONO S, Milloy MJ, Choi J, Fairbairn N, et al
    Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids.
    AIDS. 2022 May 24. pii: 00002030-990000000-00025.
    >> Share

  146. MUNOZ-MUELA E, Trujillo-Rodriguez M, Serna-Gallego A, Ruiz-Mateos E, et al
    Anti-CD4 autoantibodies in immunological non-responder people living with HIV: Cause of CD4+ T-cell depletion?
    AIDS. 2022 May 24. pii: 00002030-990000000-00019.
    >> Share

  147. VALINETZ ED, Matemo D, Gersh JK, Joudeh LL, et al
    Isoniazid preventive therapy and TB transcriptional signatures in people with HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00017.
    >> Share

  148. LOUW S, Gededzha MP, Mayne AL, Mayne ES, et al
    Thrombotic thrombocytopenic purpura (TTP) in Human immunodeficiency virus (HIV) infected patients: New twists on an old disease.
    AIDS. 2022 May 24. pii: 00002030-990000000-00023.
    >> Share

  149. INZAULE SC, Kroeze S, Kityo CM, Siwale M, et al
    Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multi-country longitudinal cohort analysis.
    AIDS. 2022 May 24. pii: 00002030-990000000-00021.
    >> Share

  150. YU X, Baillargeon J, Berenson AB, Westra JR, et al
    Incident depression among Medicare beneficiaries with disabilities and HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00020.
    >> Share

  151. VANPOUILLE C, Wells A, Wilkin T, Mathad JS, et al
    Sex differences in cytokine profiles during suppressive antiretroviral therapy.
    AIDS. 2022 May 24. pii: 00002030-990000000-00022.
    >> Share

  152. PORTWOOD C, Sexton H, Kumarendran M, Brandon Z, et al
    Adverse perinatal outcomes associated with HAART and monotherapy: systematic review and meta-analysis.
    AIDS. 2022 May 24. pii: 00002030-990000000-00018.
    >> Share

  153. LUO Q, Pfeiffer RM, Noone AM, Horner MJ, et al
    Years of life lost to cancer among the US HIV population, 2006-2015.
    AIDS. 2022 May 24. pii: 00002030-990000000-00024.
    >> Share

  154. SUAREZ-ZDUNEK MA, Hogh J, Kirkegaard-Klitbo DM, Jensen AMR, et al
    High incidence of subclinical peripheral artery disease in people with HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00016.
    >> Share

  155. GIOVENCO D, Pettifor A, Powers KA, Hightow-Weidman L, et al
    Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
    AIDS. 2022 May 17. pii: 00002030-990000000-00015.
    >> Share

  156. SHEN Y, Shiau S, Yin MT, Arpadi SM, et al
    Cytokines in HIV infection: authors' reply.
    AIDS. 2022;36:908-909.
    >> Share

  157. MUNHOZ LGC, De Moraes-Pinto MI
    Cytokines in HIV infection: different methods of assessment require different interpretations.
    AIDS. 2022;36:907-908.
    >> Share

  158. CICHOWITZ C, Masoza T, Peck RN
    Air pollution and preclinical atherosclerotic cardiovascular disease in adolescents living with HIV: an opportunity for prevention.
    AIDS. 2022;36:901-902.
    >> Share

    Strategies to improve HIV care outcomes for people with HIV who are out of care: the need for well designed health systems.
    AIDS. 2022;36:899-900.
    >> Share

  160. NEL J, Gupta-Wright A
    Urine tuberculosis diagnostics in patients with advanced HIV.
    AIDS. 2022;36:897-898.
    >> Share

    April 2022
  161. TETENS MM, Gerstoft J, Kronborg G, Johansen IS, et al
    Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00014.
    >> Share

  162. AUNG HL, Gates TM, Mao L, Brew BJ, et al
    Abnormal cognitive aging in people with HIV: Evidence from Data Integration between two countries' cohort studies.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00013.
    >> Share

  163. KAZEMIAN P, Ding DD, Scott JA, Feser MK, et al
    The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among men who have sex with men in India.
    AIDS. 2022 Apr 26. pii: 00002030-990000000-00012.
    >> Share

  164. SAX PE, Andreatta K, Molina JM, Daar ES, et al
    High Efficacy of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with Suppressed HIV and Preexisting M184 V/I.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00011.
    >> Share

  165. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
    >> Share

  166. VOGT SL, Maloma L, Xian RR, Ambinder RF, et al
    Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00009.
    >> Share

  167. WEINBERG A, Giganti MJ, Sirois PA, Montepiedra G, et al
    Coordination of inflammatory responses in children with perinatally-acquired HIV infection.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00008.
    >> Share

  168. LEVI LI, Sharma S, Schleiss MR, Furrer H, et al
    Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00007.
    >> Share

  169. PONTICIELLO M, Mwanga-Amumpaire J, Tushemereirwe P, Nuwagaba G, et al
    How informal healthcare providers improve uptake of HIV testing: qualitative results from a randomized controlled trial.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00006.
    >> Share

  170. MONTEJANO R, Marcelo C, Falces-Romero I, Del Valle LG, et al
    Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV.
    AIDS. 2022;36:751-753.
    >> Share

  171. GENER AR, Kottilil S
    Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications.
    AIDS. 2022;36:749-750.
    >> Share

  172. BERNARDINO JI, Srinivasa S
    Proprotein convertase subtilisin/kexin type 9 inhibitors: a turning point in HIV-associated dyslipidemia?
    AIDS. 2022;36:745-747.
    >> Share

  173. OLALLA-SIERRA J, Martin-Escalante MD, Garcia-Alegria J, Rubio-Rivas M, et al
    Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain.
    AIDS. 2022;36:683-690.
    >> Share

  174. FILIP I
    Getting to the heart of the matter: the need for tailored cardiovascular prevention strategies in patients with HIV.
    AIDS. 2022;36:N1-N3.
    >> Share

  175. JOSEPH J, Boeke CE, Makadzange EE, Sithole K, et al
    Near-point-of-care viral load testing during pregnancy and viremia at delivery.
    AIDS. 2022;36:711-719.
    >> Share

    March 2022
  176. MAZZITELLI M, Sasset L, Trunfio M, di Meco E, et al
    Use of self-prescribed medications and complementary medicines in a cohort of women with HIV.
    AIDS. 2022;36:617-619.
    >> Share

    HIV and SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: authors' reply.
    AIDS. 2022;36:616-617.
    >> Share

  178. HUANG J, Liao L, Wang Y, Liu Q, et al
    Antagonism between hydrogen bonding and secondary chemical bonding to calcium in viruses.
    AIDS. 2022;36:615-616.
    >> Share

  179. LEPIK KJ, Wang L, Harris M, Mclinden T, et al
    Evolving patterns of antiretroviral drug interactions in people living with HIV in British Columbia, Canada.
    AIDS. 2022 Mar 11. pii: 00002030-990000000-00005.
    >> Share

  180. LEFEBVRE M, Secher S, Bouchez S, Vandamme YM, et al
    Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00002.
    >> Share

  181. LE HINGRAT Q, Collin G, Bachelard A, Ghosn J, et al
    Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00001.
    >> Share

  182. RIAL-CRESTELO D, Otero B, Perez-Ayala A, Pinto A, et al
    Severe diarrhea by Cystoisospora belli in a well controlled HIV-infected patient.
    AIDS. 2022;36:485-486.
    >> Share

  183. SIM BZ, Smith LK, Yarwood T, Smith S, et al
    Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab.
    AIDS. 2022;36:483-485.
    >> Share

  184. XU X, Vesterbacka J, Aleman S, Nowak P, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:479-481.
    >> Share

    The persistent disparity in brain health among aging people with HIV.
    AIDS. 2022;36:475-477.
    >> Share

  186. POST JJ, Benfield T, Woolley I
    When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV.
    AIDS. 2022;36:473-474.
    >> Share

  187. STIRRUP O, Tostevin A, Ragonnet-Cronin M, Volz E, et al
    Diagnosis delays in the UK according to pre or postmigration acquisition of HIV.
    AIDS. 2022;36:415-422.
    >> Share

  188. ROUT SS, Di Y, Dittmer U, Sutter K, et al
    Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice.
    AIDS. 2022;36:325-336.
    >> Share

    February 2022
  189. PIMENTEL VF, Pingarilho M, Sole G, Alves D, et al
    Differential patterns of post-migration HIV-1 infection acquisition among Portuguese immigrants of different geographical origin.
    AIDS. 2022 Feb 25. pii: 00002030-900000000-96205.
    >> Share

  190. NANCE RM, Delaney JAC, Floyd JS, Saag MS, et al
    Risk factors for atrial fibrillation in a multi-center US clinical cohort of people with HIV infection.
    AIDS. 2022 Feb 25. pii: 00002030-900000000-96204.
    >> Share

  191. DAUBY N, Gobert C, Benslimane A, Nagant C, et al
    Durability of tetanus seroprotection in people living with HIV.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96211.
    >> Share

  192. DASGUPTA S, Crim SM, Dawson L, Kates J, et al
    Unmet needs for HIV ancillary care services by health care coverage and Ryan White HIV/AIDS program assistance.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96210.
    >> Share

  193. YAP SH, Lee CS, Furusho A, Ishii C, et al
    Plasma D-amino acids are associated with markers of immune activation and organ dysfunction in people living with HIV.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96209.
    >> Share

  194. TORIAN LV, Forgione L, Wertheim JO
    Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985-2019.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96208.
    >> Share

  195. TUMKOSIT M, Han WM, Tankittiwat K, Chattranukulchai P, et al
    Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96207.
    >> Share

  196. ZANG X, Goedel WC, Bessey SE, Lurie MN, et al
    The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: A modeling study.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96206.
    >> Share

  197. HAMIDOUCHE M, Ante-Testard PA, Baggaley R, Temime L, et al
    Monitoring socioeconomic inequalities across HIV knowledge, attitudes, behaviours and prevention in 18 sub-Saharan African countries.
    AIDS. 2022 Feb 21. pii: 00002030-900000000-96212.
    >> Share

  198. DUGUE R, Schnall R, Liu M, Brickman AM, et al
    Uncontrolled HIV and inflammation is associated with intracranial saccular aneurysm presence: a preliminary study.
    AIDS. 2022 Feb 18. pii: 00002030-900000000-96214.
    >> Share

  199. FLETCHER CV, Kroon E, Schacker T, Pinyakorn S, et al
    Persistent HIV transcription and Variable ARV penetration in lymph nodes during plasma viral suppression.
    AIDS. 2022 Feb 18. pii: 00002030-900000000-96213.
    >> Share

  200. ALI MS, Wit MDE, Chabata ST, Magutshwa S, et al
    Estimation of HIV incidence from analysis of HIV prevalence patterns by age and years since starting sex work among female sex workers in Zimbabwe.
    AIDS. 2022 Feb 16. pii: 00002030-900000000-96216.
    >> Share

  201. HAWKINS C, Kang M, Bhattacharya D, Cloherty G, et al
    Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96218.
    >> Share

  202. WANJALLA CN, Temu TM, Mashayekhi M, Warren CM, et al
    IL-17A is associated with flow-mediated dilation and IL-4 with carotid plaque in persons with HIV.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96217.
    >> Share

  203. DAVIES C, Johnson L, Sawry S, Chimbetete C, et al
    Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: cohort study from Southern Africa.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96220.
    >> Share

  204. VINK FJ, Steenbergen RDM, Kremer WW, Lissenberg-Witte BI, et al
    Post-treatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96219.
    >> Share

  205. ZEGGAGH J, Bauer R, Delaugerre C, Carette D, et al
    Incidence and risk factors for recurrent sexually transmitted infections among men who have sex with men on HIV pre-exposure prophylaxis.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96224.
    >> Share

  206. GARCIA-OTERO L, Walles J, Balcha TT, Merga G, et al
    Cardiovascular effects of intrauterine exposure to maternal HIV and antiretroviral therapy in Ethiopian infants followed from fetal life.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96223.
    >> Share

  207. HUGUELEY B, Mcclung RP, Saduvala N, Oster AM, et al
    Baseline HIV drug resistance testing: 12 U.S. jurisdictions, 2014-2019.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96222.
    >> Share

  208. MANGURIAN C, Dahiya P, Goldman ML, Corbeil T, et al
    Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96221.
    >> Share

  209. TOE S, Nagy M, Albar Z, Yu J, et al
    Ambient air pollution is associated with vascular disease in ugandan HIV positive adolescents.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96226.
    >> Share

  210. JENNINGS L, Robbins RN, Nguyen N, Ferraris C, et al
    Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in south africa.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96225.
    >> Share

  211. DURIER C, Mercier-Delarue S, Verdiere NC, Meiffredy V, et al
    A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
    AIDS. 2022;36:319-321.
    >> Share

  212. VAN EMPEL E, De Vlieg RA, Harling G, Marcus ME, et al
    Reaching for the 'first 95': a cross-country analysis of HIV self-testing in nine countries in sub-Saharan Africa.
    AIDS. 2022;36:297-304.
    >> Share

  213. LU H, Cole SR, Westreich D, Hudgens MG, et al
    Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy.
    AIDS. 2022;36:277-286.
    >> Share

  214. KUNIHOLM MH, Vasquez E, Appleton AA, Kingsley L, et al
    Cardiovascular risk score associations with frailty in men and women with or at risk for HIV.
    AIDS. 2022;36:237-347.
    >> Share

  215. DEL AMO J, Polo R, Moreno S, Jarrin I, et al
    SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
    AIDS. 2022;36:161-168.
    >> Share

  216. HERMANS LE, Hofstra LM, Schuurman R, Ter Heine R, et al
    HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment - week 96 results from the ITREMA trial.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96229.
    >> Share

  217. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
    Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
    >> Share

  218. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective cART.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96227.
    >> Share

  219. MURDOCH IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, et al
    Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?
    AIDS. 2022;36:322-323.
    >> Share

  220. GUANIRA JV, Fichtenbaum CJ
    Is it time to retire efavirenz as a first-line option worldwide?
    AIDS. 2022;36:317-318.
    >> Share

  221. JABS DA, Van Natta ML, Schneider MF, Pak JW, et al
    Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS.
    AIDS. 2022;36:177-184.
    >> Share

    January 2022
  222. WAKE RM, Govender NP, Omar SV, Ismail F, et al
    Rapid urine-based screening tests increase the yield of same-day tuberculosis diagnoses among patients living with advanced HIV disease.
    AIDS. 2022 Jan 24. pii: 00002030-900000000-96230.
    >> Share

  223. LI B, Zhang L, Liu Y, Xiao J, et al
    A novel prediction model to evaluate the probability of CD4/CD8 ratio restoration in HIV-infected individuals.
    AIDS. 2022 Jan 14. pii: 00002030-900000000-96239.
    >> Share

  224. HIGA DH, Crepaz N, Mullins MM, Adegbite-Johnson A, et al
    Strategies to improve HIV care outcomes for people with HIV who are out of care: a meta-analysis.
    AIDS. 2022 Jan 12. pii: 00002030-900000000-96232.
    >> Share

  225. BOCCARA F, Caramelli B, Calmy A, Kumar P, et al
    Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period.
    AIDS. 2022 Jan 12. pii: 00002030-900000000-96231.
    >> Share

  226. JAKABEK D, Rae CD, Brew BJ, Cysique LA, et al
    Brain aging and cardiovascular factors in HIV: A longitudinal volume and shape MRI study.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96242.
    >> Share

  227. HASSOLD N, Brichler S, Ouedraogo E, Leclerc D, et al
    Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96241.
    >> Share

  228. DE LAZZARI E, Martinez-Mimbrero A, Chivite I, Gonzalez-Cordon A, et al
    Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96240.
    >> Share

  229. CARRASCO I, Olveira A, Lancharro A, Escosa L, et al
    Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96238.
    >> Share

  230. NOVAK RM, Armon C, Battalora L, Buchacz K, et al
    Aging, trends in CD4/CD8 ratio and clinical outcomes with persistent HIV suppression in the HIV outpatient study (HOPS).
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96237.
    >> Share

  231. CLARE M, Yang J, Lake JE, Abraham AG, et al
    Diabetes mellitus is associated with declines in physical function among men with and without HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96247.
    >> Share

  232. ALEDO MG, Canizares A, Vazquez-Rodriguez P, Castro A, et al
    Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96246.
    >> Share

  233. ISFORDINK CJ, Smit C, Boyd A, de Regt MJA, et al
    Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96245.
    >> Share

  234. CAMPBELL LM, Sun-Suslow N, Heaton A, Heaton RK, et al
    Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96244.
    >> Share

  235. JAROLIMOVA J, Platt LR, Curtis MR, Philpotts LL, et al
    Curable sexually transmitted infections among women with HIV in sub-Saharan Africa: systematic review and meta-analysis.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96243.
    >> Share

  236. ANDERSON AM, Bhondoekhan F, Curanovic D, Connelly MA, et al
    GlycA is associated with neuropsychological impairment in men with HIV.
    AIDS. 2022;36:156-159.
    >> Share

  237. ODENDAAL LN, Smit DP
    A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection.
    AIDS. 2022;36:155-156.
    >> Share

  238. CALZA L, Borderi M, Colangeli V, Miani T, et al
    Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir.
    AIDS. 2022;36:153-155.
    >> Share

  239. ZHU J, Wu X
    Save young lives by determining causes of children death stratified by HIV status in resource-constrained countries.
    AIDS. 2022;36:149-151.
    >> Share

  240. GENER AR
    Anticipating HIV drug resistance with appropriate sequencing methods.
    AIDS. 2022;36:147-148.
    >> Share

  241. YANAVICH C, Perazzo H, Li F, Tobin N, et al
    A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil.
    AIDS. 2022;36:49-58.
    >> Share

  242. AUGUSTE PE, Mistry H, McCarthy ND, Sutcliffe PA, et al
    Cost-effectiveness of testing for latent tuberculosis infection in people with HIV.
    AIDS. 2022;36:1-9.
    >> Share

    December 2021
  243. KNIGHTS SM, Lazarte SM, Kainthla R, Chiao EY, et al
    Mortality disparities among patients with HIV-associated kaposi's sarcoma in the southern united states.
    AIDS. 2021 Dec 22. pii: 00002030-900000000-96248.
    >> Share

  244. MCNEIL CJ, Lee JS, Cole SR, Patel SA, et al
    Anal cancer incidence in MSM with HIV: are black men at higher risk?
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96252.
    >> Share

  245. DRAK D, Shamu T, Heron JE, Chimbetete C, et al
    Renal function and associated mortality risk in adults commencing HIV antiretroviral therapy in Zimbabwe.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96251.
    >> Share

  246. CHAUSSADE H, Le-Marec F, Coureau G, Leleux O, et al
    Incidence of lung and HPV-associated malignancies in HIV-infected patients.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96250.
    >> Share

  247. KINGWARA L, Inzaule SC, Momanyi L, Jordan MR, et al
    Impact of nucleos(t)ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor based regimens in children and adolescents in Kenya.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96249.
    >> Share

  248. SHAH S, Pilkington V, Hill A
    Is tenofovir disoproxil fumarate associated with weight loss?
    AIDS. 2021;35.
    >> Share

  249. VENTER WDF, Sokhela S, Calmy A, Mkhondwane L, et al
    Weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2021;35.
    >> Share

  250. JAMIESON L, Serenata C, Makhubele L, Sokhela S, et al
    Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial.
    AIDS. 2021;35.
    >> Share

  251. HARRIS EL, Blumer K, Perez Casas C, Ferris D, et al
    Accelerating access and scale-up of optimized antiretroviral therapy in low-income and middle-income countries: results of a coordinated end-to-end approach.
    AIDS. 2021;35.
    >> Share

  252. PAPOT E, Kaplan R, Vitoria M, Polizzotto MN, et al
    Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective.
    AIDS. 2021;35.
    >> Share

  253. SINXADI PZ, Khoo SH, Boffito M
    Pharmacokinetic interactions of modern antiretroviral therapy.
    AIDS. 2021;35.
    >> Share

  254. CHANDIWANA NC, Serenata CM, Owen A, Rannard S, et al
    Impact of long-acting therapies on the global HIV epidemic.
    AIDS. 2021;35.
    >> Share

  255. MCCLUSKEY SM, Pepperrell T, Hill A, Venter WDF, et al
    Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era.
    AIDS. 2021;35.
    >> Share

  256. VENTER WDF, Serenata C, Vitoria M, Mkhondwane L, et al
    What we have learned from antiretroviral treatment optimization efforts over the last 5 years?
    AIDS. 2021;35.
    >> Share

  257. JANUS SE, Durieux JC, Hajjari J, Carneiro H, et al
    Inflammation mediated Vitamin K and Vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy.
    AIDS. 2021 Dec 13. pii: 00002030-900000000-96253.
    >> Share

  258. LINTHWAITE B, Kronfli N, Marbaniang I, Ruppenthal L, et al
    Increased reengagement of out-of-care HIV patients using lost & found, a clinic-based intervention.
    AIDS. 2021 Dec 13. pii: 00002030-900000000-96254.
    >> Share

  259. RAWLINGS SA, Torres F, Wells A, Lisco A, et al
    Effect of HIV suppression on the cytokine network in blood and seminal plasma: A longitudinal study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96262.
    >> Share

  260. MONTEBATSI M, Lavoie MC, Blanco N, Marima R, et al
    Improving same-day ART in botswana: effects of a multifaceted national intervention.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96260.
    >> Share

  261. DALLA-POZZA P, Hentzien M, Allavena C, Maindreville AD, et al
    Progressive multifocal leukoencephalopathy in patients with immuno-virological control and at least 6 months of combination antiretroviral therapy.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96259.
    >> Share

  262. CARO-VEGAS C, Ramirez C, Landis J, Adimora AA, et al
    Molecular profiling of breast and lung cancer in women with HIV reveals high tumor mutational burden.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96258.
    >> Share

  263. SCHNEIDER JA, Hayford C, Hotton A, Tabidze I, et al
    Do partner services linked to molecular clusters yield people with viremia or new HIV? results from a historical cohort study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96257.
    >> Share

  264. GIROMETTI N, McCormack S, Tittle V, McOwan A, et al
    Rising rates of recent PrEP exposure among MSM newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96256.
    >> Share

  265. BEER L, Tie Y, Dasgupta S, McManus T, et al
    The COVID-19 pandemic and unemployment, 1 subsistence needs and mental health among adults with HIV in the United States.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96255.
    >> Share

  266. LIANG HJ, Ernst T, Cunningham E, Chang L, et al
    Contributions of chronic tobacco smoking to HIV-associated brain atrophy and cognitive deficits.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96265.
    >> Share

  267. YU W, Jacobson DL, Williams PL, Patel K, et al
    Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96264.
    >> Share

  268. BAILIN SS, Kundu S, Wellons M, Freiberg MS, et al
    Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96263.
    >> Share

  269. NIKANJAM M, Tran L, Chadwick EG, Bwakura-Dangarembizi M, et al
    Impact of CYP2B6 genotype, TB therapy and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96261.
    >> Share

  270. LEE DH, Shin JE, Kim CH
    Sudden sensorineural hearing loss with vertigo as an initial presenting symptom of HIV/AIDS patient.
    AIDS. 2021;35:2553-2555.
    >> Share

  271. CATTANEO D, Fusi M, Micheli V, Resnati C, et al
    Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens.
    AIDS. 2021;35:2551-2553.
    >> Share

  272. SARKAR S, Bhondoekhan F, Haberlen S, Palella FJ Jr, et al
    The association of adipose tissue area with subclinical coronary atherosclerosis progression in men with and without HIV.
    AIDS. 2021;35:2549-2551.
    >> Share

  273. SPINELLI MA, Brown LB, Glidden DV, Hunter K, et al
    SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
    AIDS. 2021;35:2545-2547.
    >> Share

  274. MARAGH-BASS AC, Parker S, Thompson G, Erlandson KM, et al
    'Ending the HIV epidemic': where are African American women in the plan?
    AIDS. 2021;35:2541-2544.
    >> Share

  275. SLACK C, Soudeyns H
    Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries.
    AIDS. 2021;35:2539-2540.
    >> Share

  276. TUCKER JD, Iwelunmor J, Abrams E, Donenberg G, et al
    Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research consortium.
    AIDS. 2021;35:2503-2511.
    >> Share

  277. RICHART V, Fernandez I, de Lazzari E, Berrocal L, et al
    High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption.
    AIDS. 2021;35:2463-2468.
    >> Share

  278. BOSWELL MT, Yindom LM, Hameiri-Bowen D, McHugh G, et al
    TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection.
    AIDS. 2021;35:2445-2450.
    >> Share

  279. LIU D, Liu J, Xu T, Qiao H, et al
    Longitudinal trajectories of brain volume in combined antiretroviral therapy treated and untreated simian immunodeficiency virus-infected rhesus macaques.
    AIDS. 2021;35:2433-2443.
    >> Share

    November 2021
  280. LAM JO, Lee C, Gilsanz P, Hou CE, et al
    Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
    AIDS. 2021 Nov 24. pii: 00002030-900000000-96266.
    >> Share

  281. Statin exposure and risk of cancer in people with and without HIV infection: Erratum.
    AIDS. 2021;35:2411.
    >> Share

  282. PRESSIAT C, Toni TD, Treluyer JM, Yonaba C, et al
    High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.
    AIDS. 2021;35:2409-2410.
    >> Share

  283. WANG P, McGovern M, Togo Y
    Geographic diversity in authorship of HIV randomized control trial publications.
    AIDS. 2021;35:2407-2409.
    >> Share

  284. BUKKEMS VE, Hidalgo-Tenorio C, Garcia C, van Hulzen AGW, et al
    First pharmacokinetic data of bictegravir in pregnant women living with HIV.
    AIDS. 2021;35:2405-2406.
    >> Share

  285. SNYMAN J, Sanders EJ, Ndung'u T
    COVID-19 in Africa: preexisting immunity and HIV.
    AIDS. 2021;35:2391-2393.
    >> Share

  286. DEAN LT, Chang HY, Goedel WC, Chan PA, et al
    Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA.
    AIDS. 2021;35:2375-2381.
    >> Share

  287. CARLANDER C, Lagheden C, Eklund C, Nordqvist Kleppe S, et al
    Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    AIDS. 2021;35:2367-2374.
    >> Share

  288. LUCAS GM, Winslow DL
    New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia.
    AIDS. 2021;35:2395-2397.
    >> Share

  289. VANHAMEL J, Laga M
    Measuring progress in the roll-out of pre-exposure prophylaxis: from counting what we know, to knowing what to count.
    AIDS. 2021;35:2389-2390.
    >> Share

  290. TOULOUMI G, Thomadakis C, Pantazis N, Papastamopoulos V, et al
    HIV continuum of care: bridging cross-sectional and longitudinal analyses.
    AIDS. 2021 Nov 11. pii: 00002030-900000000-96268.
    >> Share

  291. DURSTENFELD MS, Sun K, Ma Y, Rodriguez F, et al
    Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96275.
    >> Share

  292. JEUDY J, Patel P, George N, Burrowes S, et al
    Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
    >> Share

  293. CACHAY ER, Hasteh F, Mathews WC
    Using computer-assisted content analysis to advance anal dysplasia natural history research: a validation study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96273.
    >> Share

  294. BIRABAHARAN M, Strunk A, Kaelber DC, Smith DM, et al
    Sex differences in type 2 diabetes mellitus prevalence among persons with HIV: a cross-sectional analysis.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96272.
    >> Share

  295. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    >> Share

  296. NEARY J, Langat A, Singa B, Kinuthia J, et al
    Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96270.
    >> Share

  297. ALTHOFF KN, Stewart CN, Humes E, Zhang J, et al
    The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96269.
    >> Share

  298. FOWLER MG, Aizire J, Sikorskii A, Atuhaire P, et al
    Growth deficits in antiretroviral and HIV exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months-of-age.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96277.
    >> Share

  299. MUNOZ-MORENO JA, Carrillo-Molina S, Martinez-Zalacain I, Miranda C, et al
    Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96276.
    >> Share

  300. YIN W, Panakadan S, Shwe YY, Peters K, et al
    Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific.
    AIDS. 2021;35:2229-2232.
    >> Share

  301. MOSES AK, Ghazi T, Naidoo DB, Chuturgoon A, et al
    DNA methylation of MEKKK1: a strategy to reactivate the NF-kappaB pathway and reverse HIV latency.
    AIDS. 2021;35:2221-2224.
    >> Share

  302. FORD N, Crawford KW, Ameyan W
    Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups.
    AIDS. 2021;35:2217-2219.
    >> Share

  303. NICHOLS BE, Rosen S
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.
    AIDS. 2021;35:2235-2236.
    >> Share

  304. CLAASSEN CW, Lindsay B, Riedel DJ, Kafunda I, et al
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs.
    AIDS. 2021;35:2234-2235.
    >> Share

  305. HEIL EL, Pandit NS, Taylor GH
    Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors.
    AIDS. 2021;35:2232-2233.
    >> Share

  306. GENER AR
    Editorial commentary on 'the other side of screening: predictors of treatment and follow-up for anal precancers in a large health system'.
    AIDS. 2021;35:2215-2216.
    >> Share

  307. CACHAY ER, Hadigan C, Mathews WC
    Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail.
    AIDS. 2021;35:2211-2213.
    >> Share

  308. SILVEIRA ELV, Hong JJ, Amancha PK, Rogers KA, et al
    Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
    AIDS. 2021;35:2085-2094.
    >> Share

    October 2021
  309. MALMSTROM S, Wagner P, Yilmaz A, Svedhem V, et al
    Failure to restore CD4 count associated with infection-related and non-infection-related cancer.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96281.
    >> Share

  310. EL-NAHAL WG, Shen NM, Keruly JC, Jones JL, et al
    Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96280.
    >> Share

  311. BECASEN JS, Morris JD, Denard CL, Mullins MM, et al
    HIV care outcomes among transgender persons with HIV infection in the united states: a systematic review and meta-analysis, 2006-2021.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96286.
    >> Share

  312. FURSA O, Mocroft A, Lazarus JV, Amele S, et al
    The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96284.
    >> Share

  313. QUINN JR, Goyal A, Ribeiro RM, Massaccesi G, et al
    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96283.
    >> Share

  314. CEDARBAUM ER, Ma Y, Adimora AA, Bamman M, et al
    Peripheral artery disease and physical function in women with and without HIV.
    AIDS. 2021 Oct 21. pii: 00002030-900000000-96285.
    >> Share

  315. RAMOS-RINCON JM, Menchi-Elanzi M, Pinargote-Celorio H, Mayoral A, et al
    Trends in hospitalizations and deaths in HIV-Infected patients in Spain over two decades.
    AIDS. 2021 Oct 20. pii: 00002030-900000000-96291.
    >> Share

  316. MILLS A, Richmond GJ, Newman C, Osiyemi O, et al
    Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.
    AIDS. 2021 Oct 13. pii: 00002030-900000000-96294.
    >> Share

  317. SIDDIQUI J, Samuel SK, Hayward B, Wirka KA, et al
    HIV-associated wasting prevalence in the era of modern antiretroviral therapy: a claims database study (2012-2018).
    AIDS. 2021 Oct 12. pii: 00002030-900000000-96296.
    >> Share

  318. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
    Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinics in Mombasa, Kenya.
    AIDS. 2021 Oct 8. pii: 00002030-900000000-96295.
    >> Share

  319. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
    HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
    >> Share

  320. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    >> Share

  321. YAN H, Peters H, Thorne C
    Neonatal deaths among infants born to women living with HIV in the UK and Ireland 1998-2017.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96297.
    >> Share

  322. BEZEMER D, Blenkinsop A, Hall M, van Sighem A, et al
    In-country acquisition of HIV-1 non-B infection within the Netherlands is frequent, but results in limited onward transmission.
    AIDS. 2021 Oct 5. pii: 00002030-900000000-96312.
    >> Share

  323. SHAIKH K, Bhondoekhan F, Haberlen S, Nakanishi R, et al
    Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
    AIDS. 2021 Oct 4. pii: 00002030-900000000-96300.
    >> Share

  324. BOZZI G, Meneri M, Peri AM, Taramasso L, et al
    Starting HIV therapy in patients with mitochondrial disease.
    AIDS. 2021;35:2063-2065.
    >> Share

  325. SARKAR S, Haberlen S, Metkus TS, Kingsley L, et al
    HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium.
    AIDS. 2021;35:2061-2063.
    >> Share

  326. TOMIO A, Lupo J, Blanc M, Epaulard O, et al
    Dynamics of anti-HBs antibody decay in vaccinated people with HIV/AIDS.
    AIDS. 2021;35:2059-2061.
    >> Share

  327. HOOVER JR, Frymus DE, Ifafore-Calfee TA
    Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response.
    AIDS. 2021;35:2047-2050.
    >> Share

  328. WEINSTEIN ER, Lee JS, Mendez NA, Harkness A, et al
    HIV/AIDS and aging: the new frontier for HIV/AIDS research and care.
    AIDS. 2021;35:2043-2045.
    >> Share

  329. SANDERS EJ, Agutu CA, Graham SM
    Multiple HIV testing strategies are necessary to end AIDS.
    AIDS. 2021;35:2039-2041.
    >> Share

  330. KOENIG LJ, McKnight-Eily LR
    Achieving national HIV prevention goals: the case for addressing depression and other mental health comorbidities.
    AIDS. 2021;35:2035-2037.
    >> Share

  331. NACCARATO M, Kwee F, Zaltzman J, Fong IW, et al
    Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?
    AIDS. 2021;35:2065-2068.
    >> Share

    September 2021
  332. MOLDT B, Gunthard HF, Workowski KA, Little SJ, et al
    Evaluation of HIV-1 reservoir size and broadly neutralizing antibodies (bNAb) susceptibility in acute ART treated individuals.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96307.
    >> Share

  333. KYAW NTT, Kumar AMV, Harries AD, Satyanarayana S, et al
    Synergy between low body mass index and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96306.
    >> Share

  334. BREGER TL, Westreich D, Edmonds A, Edwards JK, et al
    A new smoking cessation "cascade" among women with or at risk for HIV infection.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96305.
    >> Share

  335. MCMAHON JH, Evans VA, Lau JSY, Symons J, et al
    Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96304.
    >> Share

  336. ONYANGO DO, Akelo V, van der Sande MAB, Ridzon R, et al
    Causes of death in HIV-infected and HIV-uninfected children in the child health and mortality prevention surveillance study-Kenya.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96303.
    >> Share

  337. KLINGLER J, Paul N, Laumond G, Schmidt S, et al
    Distinct antibody profiles in HLA-B*57+, HLA-B*57- HIV controllers and chronic progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96309.
    >> Share

  338. VIEIRA VA, Millar J, Adland E, Muenchhoff M, et al
    Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96308.
    >> Share

  339. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy-naive adults with HIV-1 infection.
    AIDS. 2021 Sep 15. pii: 00002030-900000000-96314.
    >> Share

  340. N'TAKPE JB, Gabillard D, Moh R, Gardiennet E, et al
    Elite and viremic HIV-1 controllers in West Africa.
    AIDS. 2021 Sep 14. pii: 00002030-900000000-96315.
    >> Share

  341. QU Y, Weinstein A, Wang Z, Cheng Y, et al
    Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    AIDS. 2021 Sep 13. pii: 00002030-900000000-96316.
    >> Share

  342. STENGER MR, Pathela P, Schumacher C, Burghardt N, et al
    Trends in HIV prevalence by self-report among MSM diagnosed and 1 reported with gonorrhea in six U.S. jurisdictions, 2010-2019.
    AIDS. 2021 Sep 10. pii: 00002030-900000000-96317.
    >> Share

  343. CORLEY MJ, Pang APS, Rasmussen TA, Tolstrup M, et al
    Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96322.
    >> Share

  344. FRANCO S, Horneros J, Soldevila L, Ouchi D, et al
    Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96321.
    >> Share

  345. CHOW FC, Callen A, Arechiga V, Saloner D, et al
    Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96320.
    >> Share

  346. YAGER JL, Brooks KM, Castillo-Mancilla JR, Nemkov C, et al
    Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium, and high adherence to F/TAF vs. F/TDF.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96319.
    >> Share

  347. ABRAHAM AG, Sun J, Sharma A, Yin MT, et al
    The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96318.
    >> Share

  348. CHAN C, Patel P, Johnson K, Vaughan M, et al
    Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia.
    AIDS. 2021;35:1878-1880.
    >> Share

  349. WANG Y, Feng R, Xu J, Shi L, et al
    An updated meta-analysis on the association between HIV infection and COVID-19 mortality.
    AIDS. 2021;35:1875-1878.
    >> Share

  350. VANCE DE, Becker JT
    Using HIV neuropsychological classification methods to predict employment status.
    AIDS. 2021;35:1859-1861.
    >> Share

  351. DOSHI RK, Greenberg AE
    Test, treat, and maintain: rapid initiation of antiretroviral therapy.
    AIDS. 2021;35:1867-1869.
    >> Share

  352. CRAWFORD KW, Nathan M
    Anal neoplasia: prevention or treatment?
    AIDS. 2021;35:1863-1865.
    >> Share

  353. SEELEY J
    Social context and tracing household wealth over time in rural Uganda 1994-2018.
    AIDS. 2021;35:1857-1858.
    >> Share

  354. SANTELLI JS, Chen I, Makumbi F, Wei Y, et al
    Household wealth and HIV incidence over time, rural Uganda, 1994-2018.
    AIDS. 2021;35:1835-1843.
    >> Share

  355. CROWELL TA, Daud II, Maswai J, Owuoth J, et al
    SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020.
    AIDS. 2021 Sep 1. pii: 00002030-900000000-96325.
    >> Share

    August 2021
  356. VISHWANATHAN SA, Zhao C, Luthra R, Khalil GK, et al
    Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from SHIV acquisition by long-acting cabotegravir in macaques.
    AIDS. 2021 Aug 20. pii: 00002030-900000000-96329.
    >> Share

  357. DAMAS J, Ledergerber B, Nadin I, Tarr PE, et al
    Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study.
    AIDS. 2021 Aug 19. pii: 00002030-900000000-96330.
    >> Share

  358. MARASINI B, Vyas HK, Lakhashe SK, Hariraju D, et al
    Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
    AIDS. 2021 Aug 16. pii: 00002030-900000000-96332.
    >> Share

  359. LLOYD AR, Savage R, Eaton E
    Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescents.
    AIDS. 2021 Aug 13. pii: 00002030-900000000-96331.
    >> Share

  360. PREMEAUX TA, Moser CB, McKhann A, Hoenigl M, et al
    Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
    AIDS. 2021 Aug 6. pii: 00002030-900000000-96334.
    >> Share

  361. DAH TTE, Yaya I, Mensah E, Coulibaly A, et al
    Rapid antiretroviral therapy initiation and its effect on treatment response in men who have sex with men in West Africa.
    AIDS. 2021 Aug 4. pii: 00002030-900000000-96335.
    >> Share

  362. PASTICCI MB, De Socio GV, Gagliardini R, Merlini E, et al
    Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse.
    AIDS. 2021;35:1708-1710.
    >> Share

  363. MICAN R, Busca Arenzana C, Vasquez J, Daroca G, et al
    Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
    AIDS. 2021;35:1707-1708.
    >> Share

  364. VAN HOEK AJ, Reitsema M, Xiridou M, van Sighem A, et al
    Offering a choice of daily and event-driven preexposure prophylaxis for men who have sex with men in the Netherlands: a cost-effectiveness analysis.
    AIDS. 2021;35:1677-1682.
    >> Share

  365. BAUGHER AR, Whiteman A, Jeffries WL 4th, Finlayson T, et al
    Black men who have sex with men living in states with HIV criminalization laws report high stigma, 23 U.S. cities, 2017.
    AIDS. 2021;35:1637-1645.
    >> Share

  366. MILLAR JR, Fatti I, Mchunu N, Bengu N, et al
    Second-generation mother-to-child HIV transmission in South Africa is characterized by poor outcomes.
    AIDS. 2021;35:1597-1604.
    >> Share

  367. PRENDERGAST AJ, Szubert AJ, Pimundu G, Berejena C, et al
    The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
    AIDS. 2021;35:1537-1548.
    >> Share

  368. MARCHETTI G, Asmuth D
    Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches.
    AIDS. 2021;35:1691-1693.
    >> Share

    Hepatitis C virus infection and cardiac dysfunction in women.
    AIDS. 2021;35:1689-1690.
    >> Share

    July 2021
  370. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    >> Share

  371. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared to HIV-unexposed.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96338.
    >> Share

  372. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Multimorbidity networks associated with frailty among middle aged and older people with HIV.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96337.
    >> Share

  373. TOSKA E, Zhou S, Laurenzi CA, Haghighat R, et al
    Predictors of secondary HIV transmission risk in a cohort of adolescents living with HIV in South Africa.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96336.
    >> Share

  374. WANG M, Boeke CE, Rioja MR, Maparo T, et al
    Feasibility and impact of near-point-of-care integrated TB/HIV testing in Malawi and Zimbabwe.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96342.
    >> Share

  375. DRAK D, Mcmanus H, Vickers T, Heron JE, et al
    Renal impairment in a large-scale HIV pre-exposure prophylaxis implementation cohort.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96341.
    >> Share

  376. SEKHAR RV
    Supplementing glycine and N-acetylcysteine (GlyNAC) rapidly improves health-related quality of life and lowers perception of fatigue in patients with HIV.
    AIDS. 2021;35:1522-1524.
    >> Share

  377. PAPAMANOLI A, Psevdos G
    False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection.
    AIDS. 2021;35:1521-1522.
    >> Share

  378. DOWNING JM, Prince DJ, Sun CJ
    Prevalence of HIV testing among black and white transgender adults, 2016-2019.
    AIDS. 2021;35:1519-1520.
    >> Share

  379. TAN CS, Reeves RK
    HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?
    AIDS. 2021;35:1503-1504.
    >> Share

  380. IPSER JC, Vera JH
    Does duration of HIV infection substitute for age as a risk factor for amyloid deposition?
    AIDS. 2021;35:1501-1502.
    >> Share

    Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis?
    AIDS. 2021;35:1499-1500.
    >> Share

    Pediatric liquid 'single tablet regimens' for HIV-a call to action.
    AIDS. 2021;35:1497-1498.
    >> Share

  383. MCBRIDE B, Shannon K, Strathdee SA, Goldenberg SM, et al
    Structural determinants of HIV/STI prevalence, HIV/STI/sexual and reproductive health access, and condom use among immigrant sex workers globally.
    AIDS. 2021;35:1461-1477.
    >> Share

  384. MARUKUTIRA T, Wood BR
    Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings.
    AIDS. 2021;35:1505-1507.
    >> Share

  385. RAMOS-RINCON JM, Pinargote H, Ramos-Belinchon C, de Mendoza C, et al
    Hepatitis delta in patients hospitalized in Spain (1997-2018).
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96346.
    >> Share

  386. SWINDELLS S, Lutz T, van Zyl L, Porteiro N, et al
    Long-acting cabotegravir + rilpivirine for HIV-1 treatment: ATLAS week 96 results.
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96345.
    >> Share

  387. GODIN A, Eaton JW, Giguere K, Marsh K, et al
    Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96350.
    >> Share

  388. ASIF S, Baxevanidi E, Hill A, Venter F, et al
    The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96351.
    >> Share

  389. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    >> Share

  390. VYAS P, Mathad JS, Leu CS, Naik S, et al
    Impact of HIV status on systemic inflammation during pregnancy.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96348.
    >> Share

  391. AKGUN KM, Krishnan S, Butt AA, Gibert CL, et al
    HIV-infected medical ICU (MICU) survivors without CD4 cell recovery are at increased risk for poor outcomes regardless of viral suppression in a national cohort.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96347.
    >> Share

  392. RONCHETTI AM, Matheron S, Galicier L, Damond F, et al
    Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
    AIDS. 2021 Jul 6. pii: 00002030-900000000-96352.
    >> Share

  393. MACPHAIL AI, McLean C, Vujovic O, Hoy JF, et al
    A 44-year-old man with an ulcerating skin rash in the setting of advanced human immunodeficiency virus infection.
    AIDS. 2021;35:1325-1326.
    >> Share

  394. LASRY A, Baker-Goering M
    Cost analyses of HIV treatment should be standardized and report cost drivers.
    AIDS. 2021;35:1311-1312.
    >> Share

  395. DASH PK, Akay-Espinoza C
    FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients.
    AIDS. 2021;35:1309-1310.
    >> Share

  396. DASH PK, Boix V
    Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
    AIDS. 2021;35:1301-1303.
    >> Share

  397. VELDSMAN KA, Laughton B, Janse van Rensburg A, Zuidewind P, et al
    Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of age.
    AIDS. 2021;35:1247-1252.
    >> Share

  398. IMBERT E, Hickey MD, Clemenzi-Allen A, Lynch E, et al
    Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
    AIDS. 2021;35:1241-1246.
    >> Share

  399. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.
    AIDS. 2021;35:1191-1199.
    >> Share

  400. CATTANEO D, Bernacchia D, Beltrami M, Resnati C, et al
    When the absence of an interaction can become clinically relevant.
    AIDS. 2021;35:1327-1328.
    >> Share

  401. WOOD BR, Pozniak AL
    Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!
    AIDS. 2021;35:1305-1307.
    >> Share

  402. KANNO Y, Hau TTT, Kurokawa R, Nomura T, et al
    Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused SIV controllers.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96355.
    >> Share

  403. JIJ OACUTE N SIA, Molina JM, Costagliola D, Supervie V, et al
    Can HIV epidemics among men who have sex with men be eliminated through participation in PrEP rollouts?
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96354.
    >> Share

  404. MWASAKIFWA GE, Amin J, Kelleher A, Boyd MA, et al
    Inflammatory biomarker and soft tissue changes among patients commencing second-line ART after first-line virological failure.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96353.
    >> Share

    June 2021
  405. SANTOS JCV, Orsi JSR, Ribeiro VS, Tuon FF, et al
    The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96357.
    >> Share

  406. GILMORE JC, Zhang G, Cameron DW, Serghides L, et al
    Impact of in utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96356.
    >> Share

  407. LESKO CR, Hutton HE, Fojo AT, Shen NM, et al
    Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96361.
    >> Share

  408. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    >> Share

  409. BURKE RM, Henrion MYR, Mallewa J, Masamba L, et al
    Incidence of HIV-positive admission and inpatient mortality in Malawi [2012-2019]: a population cohort study.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96359.
    >> Share

  410. CREPAZ N, Song R, Lyss S, Hall HI, et al
    Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014-2018.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96358.
    >> Share

  411. MHLEKUDE B, Lenman A, Sidoyi P, Joseph J, et al
    The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission.
    AIDS. 2021 Jun 21. pii: 00002030-900000000-96362.
    >> Share

  412. KREBS E, Enns E, Zang X, Mah CS, et al
    Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US cities.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96365.
    >> Share

  413. SUZUKI K, Levert A, Yeung J, Starr M, et al
    HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96364.
    >> Share

  414. ROWLINSON E, Mawandia S, Ledikwe J, Bakae O, et al
    HIV testing criteria to reduce testing volume and increase positivity in Botswana.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96367.
    >> Share

  415. ZIMBA S, Nutakki A, Chishimba L, Chomba M, et al
    Risk factors and outcomes of HIV-associated stroke in Zambia.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96366.
    >> Share

  416. CHAN TY, De Zan V, Gregg A, Alagaratnam J, et al
    Cerebrospinal fluid HIV RNA escape symptomatology.
    AIDS. 2021 Jun 15. pii: 00002030-900000000-96370.
    >> Share

  417. GRANGER LA, Huettner I, Debeljak F, Kaleebu P, et al
    Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection SPARTAC cohort.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96373.
    >> Share

  418. MORROW M, Mawhinney S, Coyle RP, Coleman SS, et al
    Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96372.
    >> Share

  419. FAJNZYLBER J, Sharaf R, Hutchinson JN, Aga E, et al
    Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96371.
    >> Share

  420. SHEN Y, Shiau S, Strehlau R, Burke M, et al
    Persistently lower bone mass and bone turnover among south african children living with well-controlled HIV.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96369.
    >> Share

  421. GENBERG BL, Wilson-Barthes MG, Omodi V, Hogan JW, et al
    Microfinance, retention in care, and mortality among patients enrolled in HIV 2 Care in East Africa.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96376.
    >> Share

  422. CLAYTOR JD, Viramontes O, Conner S, Wen KW, et al
    TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96375.
    >> Share

  423. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    >> Share

  424. NWOGU JN, Gandhi M, Owen A, Khoo S, et al
    Associations between efavirenz concentrations, pharmacogenetics, and neurocognitive performance in people living with HIV in Nigeria.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96381.
    >> Share

  425. ROLLE CP, Berhe M, Singh T, Ortiz R, et al
    Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96380.
    >> Share

  426. HEATH K, Levi J, Hill A
    Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96379.
    >> Share

  427. ROBERTSON J, Eden A, Nystrom K, Hagberg L, et al
    Increased immune activation and signs of neuronal injury in HIV-negative people on pre-exposure prophylaxis (PrEP).
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96378.
    >> Share

  428. KOEHN K, Cassidy-Matthews C, Pearce M, Aspin C, et al
    Rates of new HIV diagnoses among Indigenous peoples in Canada, Australia, New Zealand, and the United States: 2009-2017.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96377.
    >> Share

  429. GABRIEL EM, Salinas TRW, Gosselin A, Larouche-Anctil E, et al
    Overt IL-32 Isoform Expression at Intestinal Level during HIV-1 Infection is Negatively Regulated by IL-17A.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96384.
    >> Share

  430. HERRERA C, Harman S, Aldon Y, Rogers P, et al
    The entry inhibitor DS003 (BMS-599793), a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96382.
    >> Share

  431. ANDREIA A, Cappello C, Stirrup O
    High-risk hpv, precancerous lesions and cancer in anal condylomas: systematic review and meta-analysis.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96383.
    >> Share

  432. GUARDIGNI V, Toschi A, Badia L, Del Turco ER, et al
    Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96387.
    >> Share

  433. JIN F, Amin J, Guy R, Vaccher S, et al
    Adherence to daily HIV Pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96386.
    >> Share

  434. MAKADZANGE TA, Hlupeni A, Machekano R, Boyd K, et al
    Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96385.
    >> Share

  435. PETERSON M, Sarita Shah N, Smith-Jeffcoat SE, Nichols C, et al
    Global progress and gaps in tuberculosis screening and treatment among people with HIV: experience from 32 countries.
    AIDS. 2021;35:1154-1156.
    >> Share

  436. NIGHTINGALE S, Dreyer AJ, Gisslen M, Winston A, et al
    Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    AIDS. 2021;35:1152-1153.
    >> Share

  437. WIERSINGA WJ, van der Valk M
    Severe coronavirus disease 2019 in a patient with HIV-2 infection.
    AIDS. 2021;35:1151-1152.
    >> Share

  438. VIEIRA VA, Fairlie L
    Effects of preconception antiretroviral therapy in placenta development and pregnancy outcomes.
    AIDS. 2021;35:1139-1141.
    >> Share

  439. ROMANELLI A, Moore D
    The importance of wearables: sleep assessment devices for people with HIV.
    AIDS. 2021;35:1137-1138.
    >> Share

    Disregarding drug resistance mutations without peril.
    AIDS. 2021;35:1135-1136.
    >> Share

  441. BOYD AT, Ogbanufe O, Onyenuobi C, Mgbakor I, et al
    Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020.
    AIDS. 2021;35:1127-1134.
    >> Share

  442. BOURDON M, Garnier A, Maignien C, Marcellin L, et al
    Assisted reproductive technology outcomes in women with a chronic viral disease.
    AIDS. 2021;35:1073-1081.
    >> Share

  443. ACKERMAN P, Thompson M, Molina JM, Aberg J, et al
    Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.
    AIDS. 2021;35:1061-1072.
    >> Share

  444. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    >> Share

  445. HAMEIRI-BOWEN D, Sovershaeva E, Flaegstad T, Gutteberg TJ, et al
    Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96389.
    >> Share

  446. APARICIO JM, Xu Y, Li Y, Colantuoni C, et al
    Plasma microRNAs are associated with domain-specific cognitive function in people with HIV.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96388.
    >> Share

    May 2021
  447. BADE AN, Gendelman HE, McMillan J, Liu Y, et al
    Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue.
    AIDS. 2021 May 27. pii: 00002030-900000000-96396.
    >> Share

  448. STIER EA, Engels E, Horner MJ, Robinson B, et al
    Cervical cancer incidence stratified by age in women living with HIV compared with the general population in the United States, 2002-2016.
    AIDS. 2021 May 27. pii: 00002030-900000000-96395.
    >> Share

  449. PAPASAVVAS E, Azzoni L, Ross BN, Fair M, et al
    Comparable HIV suppression by pegylated-IFN-alpha2a or pegylated-IFN-alpha2b during a 4-week analytical treatment interruption.
    AIDS. 2021 May 27. pii: 00002030-900000000-96394.
    >> Share

    Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
    AIDS. 2021 May 27. pii: 00002030-900000000-96393.
    >> Share

  451. CORMA-GOMEZ A, Macias J, Tellez F, Morano L, et al
    Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
    AIDS. 2021 May 27. pii: 00002030-900000000-96392.
    >> Share

  452. YU X, Westra JR, Giordano TP, Berenson AB, et al
    Assessing comorbidities and survival in HIV-infected and uninfected matched Medicare enrollees.
    AIDS. 2021 May 27. pii: 00002030-900000000-96391.
    >> Share

  453. TEMU TM, Wagoner J, Masyuko S, O'Connor A, et al
    Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya.
    AIDS. 2021 May 24. pii: 00002030-900000000-96400.
    >> Share

  454. KOWALSKA JD, Pelchen-Matthews A, Ryom L, Losso MH, et al
    Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015.
    AIDS. 2021 May 24. pii: 00002030-900000000-96399.
    >> Share

  455. NOVITSKY V, Steingrimsson J, Howison M, Dunn C, et al
    Longitudinal typing of molecular HIV clusters in a statewide epidemic.
    AIDS. 2021 May 24. pii: 00002030-900000000-96398.
    >> Share

  456. TU W, Johnson E, Fujiwara E, Gill MJ, et al
    Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning.
    AIDS. 2021 May 24. pii: 00002030-900000000-96397.
    >> Share

  457. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    High conversion of tuberculin skin tests during the first year of ART among South African adults in primary care.
    AIDS. 2021 May 19. pii: 00002030-900000000-96402.
    >> Share

  458. SILVERA R, Martinson T, Gaisa MM, Liu Y, et al
    The other side of screening: predictors of treatment and follow-up for anal precancers in a large health system.
    AIDS. 2021 May 19. pii: 00002030-900000000-96401.
    >> Share

  459. VAN DEN ELSHOUT MAM, Hoornenborg E, Achterbergh RCA, Coyer L, et al
    Improving adherence to daily PrEP among MSM in Amsterdam by providing feedback via a mobile application.
    AIDS. 2021 May 17. pii: 00002030-900000000-96403.
    >> Share

  460. PASTORI C, Galli L, Siracusano G, Spagnuolo V, et al
    Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1 infected subjects.
    AIDS. 2021 May 14. pii: 00002030-900000000-96404.
    >> Share

  461. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    >> Share

  462. DHAIRYAWAN R, Okhai H, Hill T, Sabin CA, et al
    Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.
    AIDS. 2021 May 10. pii: 00002030-900000000-96411.
    >> Share

  463. HAMADY A, Cooke GS, Garvey LJ
    Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
    AIDS. 2021 May 10. pii: 00002030-900000000-96410.
    >> Share

  464. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
    Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    AIDS. 2021 May 10. pii: 00002030-900000000-96408.
    >> Share

  465. PATHELA P, Jamison K, Braunstein SL, Borges CM, et al
    Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression.
    AIDS. 2021 May 10. pii: 00002030-900000000-96407.
    >> Share

  466. KEENE CM, Griesel R, Zhao Y, Gcwabe Z, et al
    Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line in adults failing a tenofovir-based first-line regimen: a prospective cohort study.
    AIDS. 2021 May 10. pii: 00002030-900000000-96409.
    >> Share

  467. MACHINGURA F, Chabata S, Busza J, Jamali G, et al
    Potential reduction in female sex workers' risk of contracting HIV during Covid-19.
    AIDS. 2021 May 7. pii: 00002030-900000000-96406.
    >> Share

  468. ROYSTON L, Isnard S, Calmy A, Routy JP, et al
    Kaposi sarcoma in ART-treated people living with HIV: A wake-up call for research on HHV-8.
    AIDS. 2021 May 5. pii: 00002030-900000000-96414.
    >> Share

  469. GARBER DA, Guenthner P, Mitchell J, Ellis S, et al
    Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
    AIDS. 2021 May 5. pii: 00002030-900000000-96412.
    >> Share

  470. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    >> Share

  471. KUMWENDA T, Buleya S, Matanje B, Heller T, et al
    Cardiovascular risk assessment for primary prevention in Malawian HIV patients on ART: are measurements of glycated hemoglobin and lipids worth the effort?
    AIDS. 2021;35:997-999.
    >> Share

  472. LAPARRA A, Lerolle N, Gerin M, Cheret A, et al
    Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients.
    AIDS. 2021;35:995-997.
    >> Share

  473. TARAMASSO L, Stapleton JT, Siedner MJ
    Weight gain and aging in people with HIV.
    AIDS. 2021;35:987-989.
    >> Share

    Maternal HIV infection and antiretroviral exposure during pregnancy in fetuses and newborns: when solving one problem opens up a Pandora's box of new conundrums.
    AIDS. 2021;35:985-986.
    >> Share

  475. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed.
    AIDS. 2021;35:921-931.
    >> Share

  476. SHADE SB, Osmand T, Kwarisiima D, Brown LB, et al
    Costs of integrating hypertension care into HIV care in rural East African clinics.
    AIDS. 2021;35:911-919.
    >> Share

  477. LEAL VNC, Reis EC, Fernandes FP, Soares JLDS, et al
    Common pathogen-associated molecular patterns induce the hyper-activation of NLRP3 inflammasome in circulating B lymphocytes of HIV-infected individuals.
    AIDS. 2021;35:899-910.
    >> Share

  478. CHAN MS, Morales A, Zlotorzynska M, Sullivan P, et al
    Estimating the influence of Twitter on pre-exposure prophylaxis use and HIV testing as a function of rates of men who have sex with men in the United States.
    AIDS. 2021;35.
    >> Share

  479. LI Z, Qiao S, Jiang Y, Li X, et al
    Building a social media-based HIV risk behavior index to inform the prediction of HIV new diagnosis: a feasibility study.
    AIDS. 2021;35.
    >> Share

  480. ZHENG C, Wang W, Young SD
    Identifying HIV-related digital social influencers using an iterative deep learning approach.
    AIDS. 2021;35.
    >> Share

  481. WANG B, Liu F, Deveaux L, Ash A, et al
    Adolescent HIV-related behavioural prediction using machine learning: a foundation for precision HIV prevention.
    AIDS. 2021;35.
    >> Share

  482. ZENG C, Zhang J, Sun X, Li Z, et al
    County-level predictors of retention in care status among people living with HIV in South Carolina from 2010 to 2016: a data-driven approach.
    AIDS. 2021;35.
    >> Share

  483. YANG X, Zhang J, Chen S, Weissman S, et al
    Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach.
    AIDS. 2021;35.
    >> Share

  484. CHEN S, Owolabi Y, Dulin M, Robinson P, et al
    Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA.
    AIDS. 2021;35.
    >> Share

  485. OLATOSI B, Sun X, Chen S, Zhang J, et al
    Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina.
    AIDS. 2021;35.
    >> Share

  486. WEISSMAN S, Yang X, Zhang J, Chen S, et al
    Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis.
    AIDS. 2021;35.
    >> Share

  487. OLATOSI B, Vermund SH, Li X
    Power of Big Data in ending HIV.
    AIDS. 2021;35.
    >> Share

  488. HASSOLD N, Baltes V, Martin A, Mechai F, et al
    Hemorrhagic cystitis from BK virus in a patient with AIDS.
    AIDS. 2021;35:999-1001.
    >> Share

    April 2021
  489. BROUILLETTE MJ, Koski L, Forcellino L, Gasparri J, et al
    Predicting occupational outcomes from neuropsychological test performance in older people with HIV.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96417.
    >> Share

  490. HUNG R, Patel N, Fox J, Cosgrove C, et al
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96416.
    >> Share

  491. MCCANN K, Shah S, Hindley L, Hill A, et al
    Implications of weight gain with newer antiretrovirals: 10-year predictions of cardiovascular disease and diabetes.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96415.
    >> Share

  492. DIRAJLAL-FARGO S, Sattar A, Yu J, Albar Z, et al
    Lipidome Association with Vascular Disease and Inflammation in HIV+ Ugandan Children.
    AIDS. 2021 Apr 19. pii: 00002030-900000000-96419.
    >> Share

  493. SLAMA L, Barrett BW, Abraham AG, Palella FJ Jr, et al
    Risk for incident diabetes is greater in pre-diabetic men with HIV than without HIV.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96422.
    >> Share

  494. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    >> Share

  495. LAU JSY, McMahon JH, Gubser C, Solomon A, et al
    The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96420.
    >> Share

  496. KALMIN MM, Westreich D, Drummond BM, Sun J, et al
    Incident obstructive lung disease and mortality among HIV-positive and negative persons with a history of injecting drugs.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96436.
    >> Share

  497. SANDAMANN L, Stoll M, Behrens GMN
    Hypophosphatemia in people living with HIV: No benefit when switching from TDF to TAF.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96435.
    >> Share

  498. SEKABIRA R, Mcgowan I, Yuhas K, Brand RM, et al
    Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96434.
    >> Share

  499. JENNESS SM, Knowlton G, Smith DK, Marcus JL, et al
    A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96433.
    >> Share

  500. GIANOTTI N, Galli L, Poli A, Torre LD, et al
    Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96432.
    >> Share

  501. SADOUNI M, Durand M, Boldeanu I, Danielli C, et al
    Association of Epicardial Fat with Non-Calcified Coronary Plaque Volume and With Low Attenuation Plaque in People Living with HIV.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96431.
    >> Share

  502. KARIUKI SM, Selhorst P, Abrahams MR, Rebe K, et al
    Neutralization sensitivity of genital tract HIV-1: shift in selective milieu shapes the population available to transmit.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96430.
    >> Share

  503. BASTARD JP, Pelloux V, Alili R, Fellahi S, et al
    Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96429.
    >> Share

  504. APORNPONG T, Grinsztejn B, Hughes M, Ritz J, et al
    Antiretroviral Hair Levels, Self-Reported Adherence and Virologic Failure in Second-Line Regimen Patients in Resource-Limited Settings.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96428.
    >> Share

  505. MACBRAYNE CE, Rutstein RM, Wiznia AA, Graham B, et al
    Etravirine in treatment-experienced HIV-1 infected children 1-<6 years of age.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96427.
    >> Share

  506. FEINSTEIN MJ, Haberlen SA, Ashikaga H, Palella FJ, et al
    Ventricular ectopy and arrhythmia by HIV serostatus, viremia, and CD4+ cell count.
    AIDS. 2021;35:846-849.
    >> Share

  507. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.
    >> Share

  508. DRAK D, Dahwa R, Reakes E, Heron JE, et al
    Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy.
    AIDS. 2021;35:843-845.
    >> Share

  509. IKUMI NM, Malaba TR, Pillay K, Cohen MC, et al
    Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women.
    AIDS. 2021;35:717-726.
    >> Share

  510. STECHER C, Linnemayr S
    Promoting antiretroviral therapy adherence habits: a synthesis of economic and psychological theories of habit formation.
    AIDS. 2021;35:711-716.
    >> Share

    March 2021
  511. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    >> Share

  512. BERGLOV A, Moseholm E, Katzenstein TL, Johansen IS, et al
    Prevalence and association with birth outcomes of low Vitamin D levels among pregnant women living with HIV.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96440.
    >> Share

  513. MORGELLO S, Cortes EP, Gensler G, Meloni G, et al
    HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96439.
    >> Share

  514. RAVA M, Bisbal O, Dominguez-Dominguez L, Aleman MR, et al
    Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96438.
    >> Share

  515. MAXI JK, Foret BL, Amedee A, Mcdaniel LS, et al
    ART administration reduces neuroinflammation without restoring BDNF signaling in alcohol-administered SIV-infected macaques.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96437.
    >> Share

  516. COLLINS LF, Shantha JG, Nesper PL, Sheth AN, et al
    Assessment of retinal microvascular health by optical coherence tomography angiography among persons with HIV.
    AIDS. 2021 Mar 23. pii: 00002030-900000000-96442.
    >> Share

  517. GROVE M, Brown LL, Knudsen HK, Martin EG, et al
    Employing telehealth within HIV care: Advantages, challenges, and recommendations.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96447.
    >> Share

  518. LIN SH, Wang Y, Hartley SW, Karyadi DM, et al
    In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96446.
    >> Share

  519. SMITH T, Masciotra S, Luo W, Sullivan V, et al
    Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96445.
    >> Share

  520. LAKE JE, LA K, Erlandson KM, Adrian S, et al
    Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96444.
    >> Share

  521. TRAN H, Saleem K, Lim M, Chow EPF, et al
    Global estimates for the lifetime cost of managing HIV: a systematic review.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96443.
    >> Share

  522. JAO J, Jacobson DL, Russell JS, Wang J, et al
    Perinatally acquired HIV infection is associated with abnormal blood mitochondrial function during childhood/adolescence.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96451.
    >> Share

  523. CUTRELL AG, Schapiro JM, Perno CF, Kuritzkes DR, et al
    Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis across three phase 3 studies.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96450.
    >> Share

  524. CLUVER L, Shenderovich Y, Toska E, Rudgard WE, et al
    Clinic and care: associations with adolescent ART adherence in a prospective cohort in South Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96449.
    >> Share

  525. NGUYEN PT, Gilmour S, Le PM, Onishi K, et al
    Progress toward HIV elimination goals: trends in and projections of Annual HIV testing and condom use in Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96448.
    >> Share

  526. BUTEL-SIMOES G, Woolley I, McMahon J, Yeo A, et al
    IgG4-related disease masquerading as a fungating groin lesion in a patient with HIV and incomplete immune reconstitution.
    AIDS. 2021;35:706-707.
    >> Share

  527. HIREMATH PM, Suri D, Arora K, Shandilya J, et al
    Human leukocyte antigen B27 and B57 alleles in HIV-infected long-term nonprogressor children.
    AIDS. 2021;35:703-705.
    >> Share

  528. AGWU AL, Flynn PM
    Increasing the urgency to identify adolescents and young adults with HIV or die.
    AIDS. 2021;35:693-695.
    >> Share

  529. LURAIN K, Mbulaiteye SM
    Does HIV undermine breast cancer outcomes in women?
    AIDS. 2021;35:689-690.
    >> Share

  530. KOJIMA N, Klausner JD
    Preexposure prophylaxis is effective on a national level, but is it enough.
    AIDS. 2021;35:691-692.
    >> Share

  531. METSU D, Aquilina C, Delobel P, Gandia P, et al
    Maraviroc exposure is influenced by exogenous thyrotoxicosis.
    AIDS. 2021;35:701-703.
    >> Share

  532. PETT SL, Spyer M, Haddow LJ, Nhema R, et al
    Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
    AIDS. 2021;35:585-594.
    >> Share

  533. DALEL J, Ung SK, Hayes P, Black SL, et al
    HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96472.
    >> Share

  534. THIMM MA, Eke AC
    Tenofovir, pregnancy and renal function changes in pregnant women living with HIV.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96471.
    >> Share

  535. DEJONG C, Spinelli MA, Okochi H, Gandhi M, et al
    Tenofovir-based PrEP for COVID-19: an untapped opportunity?
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96470.
    >> Share

  536. BULSTRA CA, Reddy CL, Atun R, Barnighausen T, et al
    Impact of the COVID-19-related global recession on the financing of the global HIV response.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96469.
    >> Share

  537. FRENCH AL, Grennan D, Daubert E, Seaberg EC, et al
    Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96468.
    >> Share

  538. NICKOLAS TL, Barasch J, Mugwanya KK, Branch AD, et al
    Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96467.
    >> Share

  539. MERCURIO V, Fitzgerald W, Vanpouille C, Molodtsov I, et al
    Mechanisms of residual immune activation in HIV-1 infected human lymphoid tissue ex vivo.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96466.
    >> Share

  540. TAKAHASHI N, Ardeshir A, Holder GE, Cai Y, et al
    Comparison of predictors for terminal disease progression in SIV/SHIV-infected rhesus macaques.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96465.
    >> Share

  541. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96464.
    >> Share

  542. KAPETANOVIC S, Giganti MJ, Abzug MJ, Lindsey JC, et al
    Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96463.
    >> Share

  543. WANG Z, Manion MM, Laidlaw E, Rupert A, et al
    Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96458.
    >> Share

  544. MOUNZER K, Brunet L, Wyatt CM, Fusco JS, et al
    To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96461.
    >> Share

  545. TAPIA GR, Glynn TR, Miller C, Manuzak JA, et al
    Syndemics and pre-exposure prophylaxis are independently associated with rectal immune dysregulation in sexual minority men.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96460.
    >> Share

  546. CONNOLLY S, Carlson JM, Schaefer M, Bere A, et al
    HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4 decline in Zambian transmission pairs.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96459.
    >> Share

  547. MORTON T, Chege W, Swann E, Senn TE, et al
    Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioral science: NIH workshop directions.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96457.
    >> Share

  548. VAN DEN HOF M, Jellema PEJ, Haar AMT, Scherpbier HJ, et al
    Normal structural brain development in adolescents treated for perinatally acquired HIV: A longitudinal imaging study.
    AIDS. 2021 Mar 8. pii: 00002030-900000000-96462.
    >> Share

  549. A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India: Erratum.
    AIDS. 2021;35:527.
    >> Share

  550. LUO G, Su L, Hu X, Lin YF, et al
    The role of e-commerce platforms in optimizing the HIV care continuum.
    AIDS. 2021;35:521-522.
    >> Share

  551. VANCE DE, Brew BJ
    HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
    AIDS. 2021;35:511-513.
    >> Share

  552. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.
    >> Share

  553. ALDREDGE A, Roth G, Vaidya A, Paula Duarte A, et al
    Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.
    AIDS. 2021;35:524-526.
    >> Share

  554. CATTANEO D, Vinti P, Baldelli S, Fusi M, et al
    Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.
    AIDS. 2021;35:522-524.
    >> Share

    February 2021
  555. DE FRANCESCO D, Sabin CA, Winston A, Mallon PWG, et al
    Agreement between self-reported and objective measures of sleep in people with HIV and lifestyle-similar HIV-negative individuals.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96476.
    >> Share

  556. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    >> Share

  557. GUARALDI G, Calza S, Milic J, Calcagno A, et al
    Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96474.
    >> Share

  558. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    >> Share

  559. JAN AK, Moore JV, Wang RJ, Mcging M, et al
    Markers of inflammation and immune activation are associated with lung function in a multicenter cohort of persons with HIV.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96477.
    >> Share

  560. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    >> Share

  561. HAYS AG, Schar M, Barditch-Crovo P, Bagchi S, et al
    A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96486.
    >> Share

  562. HOLT M, Broady TR, Mao L, Chan C, et al
    Increasing pre-exposure prophylaxis use and 'net prevention coverage' in behavioural surveillance of Australian gay and bisexual men, 2014-19.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96485.
    >> Share

  563. KIMMEL SD, Walley AY, Lodi S, Forman LS, et al
    Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96484.
    >> Share

  564. HATCHER AM, Brittain K, Phillips TK, Zerbe A, et al
    Longitudinal association between intimate partner violence and viral suppression during pregnancy and postpartum in South African women.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96483.
    >> Share

  565. NELSON M, Winston A, Hill A, Mngqibisa R, et al
    Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96482.
    >> Share

  566. MOODLEY Y, Tomita A, de Oliveira T, Tanser F, et al
    HIV viral load and pregnancy loss: Results from a population-based cohort study in rural KwaZulu-Natal, South Africa.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96481.
    >> Share

  567. SHIAU S, Brummel SS, Kennedy EM, Hermetz K, et al
    Longitudinal changes in epigenetic age in youth with perinatally-acquired HIV and youth who are perinatally HIV-exposed uninfected.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96480.
    >> Share

  568. EKENBERG C, Reekie J, Zucco AG, Murray DD, et al
    The association of HLA alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96479.
    >> Share

  569. YANG FN, Bronshteyn M, Flowers SA, Dawson M, et al
    Low CD4 nadir exacerbates the impacts of APOE epsilon4 on functional connectivity and memory in adults with HIV.
    AIDS. 2021 Feb 5. pii: 00002030-900000000-96491.
    >> Share

  570. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Prospective evaluation of blood Epstein Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.
    AIDS. 2021 Feb 5. doi: 10.1097/QAD.0000000000002839.
    >> Share

  571. MELLOR MM, Bast AC, Jones NR, Roberts NW, et al
    Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96494.
    >> Share

  572. ZOU W, Xing J, Wang F, Chen X, et al
    HIV-1LAI Nef blocks the development of hematopoietic stem/ progenitor cells into T lymphoid cells.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96493.
    >> Share

  573. ROTHAN C, Yero A, Shi T, Farnos O, et al
    ART-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96492.
    >> Share

  574. HAMZAH L, Post FA
    Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravir.
    AIDS. 2021;35:349-351.
    >> Share

  575. ROTHERAM-BORUS MJ, Wynn A, Stewart J, Almirol E, et al
    Outcomes of HIV-exposed but uninfected children in South Africa over 5 years.
    AIDS. 2021;35:347-349.
    >> Share

  576. JOSEPH DAVEY DL, de Villiers L, Evens E
    Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.
    AIDS. 2021;35:335-336.
    >> Share

  577. MOYO F, Mazanderani AH, Murray T, Sherman GG, et al
    Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    AIDS. 2021;35:307-316.
    >> Share

  578. SALVATORE PP, de Broucker G, Vojnov L, Moss WJ, et al
    Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
    AIDS. 2021;35:287-297.
    >> Share

  579. MCENTIRE CRS, Fong KT, Jia DT, Cooper ER, et al
    Central nervous system disease with JC virus infection in adults with congenital HIV.
    AIDS. 2021;35:235-244.
    >> Share

  580. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    >> Share

  581. CAZZANIGA A, Scrimieri R, Galli M, Maier J, et al
    Unveiling the basis of antiretroviral therapy-induced osteopenia: the effects of Dolutegravir, Darunavir and Atazanavir on osteogenesis.
    AIDS. 2021;35:213-218.
    >> Share

  582. WANG Y, Lin X, Wen Y
    Organizing pneumonia-presenting acute respiratory distress syndrome because of paradoxical tuberculosis-immune reconstitution disease?
    AIDS. 2021;35:351-354.
    >> Share

    January 2021
  583. WANG L, Moqueet N, Simkin A, Knight J, et al
    Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96503.
    >> Share

  584. MADEDDU G, De Vito A, Cozzi-Lepri A, Cingolani A, et al
    Time spent with viral load
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96502.
    >> Share

  585. OLIVEIRA NL, Kennedy EH, Tibshirani R, Levine A, et al
    Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96501.
    >> Share

  586. MUCCINI C, Galli L, Poli A, Godino C, et al
    Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96500.
    >> Share

  587. GEBREBRHAN H, Kambaran C, Sivro A, Adhiambo W, et al
    Rectal microbiota diversity in Kenyan men who have sex with men (MSM) is inversely associated with frequency of receptive anal sex, independent of HIV status.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96499.
    >> Share

  588. CHAN P, Kerr SJ, Kroon E, Colby D, et al
    Cognitive trajectories after treatment in acute HIV infection.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96498.
    >> Share

  589. NYAKATO P, Schomaker M, Sipambo N, Technau KG, et al
    Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa.
    AIDS. 2021 Jan 21. pii: 00002030-900000000-96504.
    >> Share

  590. ARANTES I, Bello G, Darcissac E, Lacoste V, et al
    Using phylogenetic surveillance and epidemiological data to understand the HIV-1 transmission dynamics in French Guiana.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96506.
    >> Share

  591. JOHNSTON PI, Wright SW, Orr M, Pearce FA, et al
    Worldwide relative smoking prevalence among people living with and without HIV: a systematic review and meta-analysis.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96505.
    >> Share

    Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96508.
    >> Share

  593. KANG R, Li J, Chen H, Tang Z, et al
    Using longitudinal genetic-network study to understand HIV treatment-as-prevention: a population-based observational study.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96507.
    >> Share

  594. LIU FF, Hall V, Cronin KM, Nair AP, et al
    'Peeling back the onion layers': the challenge of HIV-associated multicentric Castleman's disease.

    AIDS. 2021;35:159-161.
    >> Share

  595. ASHOK A, Hoy J, Spelman D, McMahon J, et al
    Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV.
    AIDS. 2021;35:157-158.
    >> Share

  596. TRAEGER MW, Patel P, Guy R, Hellard ME, et al
    Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
    AIDS. 2021;35:155-157.
    >> Share

  597. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2021;35:151-154.
    >> Share

  598. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    AIDS. 2021;35:53-62.
    >> Share

    December 2020
  599. LAM JO, Hou CE, Hojilla JC, Anderson AN, et al
    Comparison of dementia risk after age 50 between individuals with and without HIV infection.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  600. BRANDAO M, Bruzzone M, Franzoi MA, de Angelis C, et al
    Impact of HIV infection on baseline characteristics and survival of women with breast cancer: a systematic review and meta-analysis.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  601. RITTENHOUSE KJ, Mwape H, Nelson JA, Mwale J, et al
    Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  602. NTHOBATSANG K, Ncenga TL, Mwangi-Woto C, Wedu TJ, et al
    Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  603. BUDD A, Krentz HB, Rubin LH, Power C, et al
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  604. NGONGO NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  605. TORDOFF DM, Buskin S, Lechtenberg R, Golden MR, et al
    Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
    AIDS. 2020 Dec 10. doi: 10.1097/QAD.0000000000002783.
    >> Share

  606. KIMURA CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002795.
    >> Share

  607. HICKEY MD, Imbert E, Glidden DV, Rosario JBD, et al
    Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002793.
    >> Share

  608. MOCROFT A
    The relationship between smoking, current CD4, viral load and cancer in persons living with HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002791.
    >> Share

  609. FALASCA K, Lanuti P, Ucciferri C, Pieragostino D, et al
    Circulating extracellular vesicles as new inflammation marker in hiv infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002794.
    >> Share

  610. HANDOKO R, Chan P, Jagodzinski L, Pinyakorn S, et al
    Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002786.
    >> Share

  611. MU W, Sharma M, Heymans R, Ritou E, et al
    ApoA-I mimetics attenuate macrophage activation in chronic treated HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002785.
    >> Share

  612. XIANG Y, Fujimoto K, Li F, Wang Q, et al
    Identifying influential neighbors in social networks and venue affiliations among young MSM: A data science approach to predict HIV infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002784.
    >> Share

  613. FIORENTINO M, Eubanks A, Coulaud PJ, Couderc C, et al
    Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa (CohMSM).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002782.
    >> Share

  614. ESTCOURT C, Yeung A, Nandwani R, Goldberg D, et al
    Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM.
    AIDS. 2020 Dec 7. doi: 10.1097/QAD.0000000000002790.
    >> Share

  615. BAILEY JV, Wayal S, Aicken CRH, Webster R, et al
    Interactive digital interventions for prevention of sexually transmitted HIV: systematic review and meta-analyses.
    AIDS. 2020 Dec 4. doi: 10.1097/QAD.0000000000002780.
    >> Share

  616. ONG JJ, Chow EPF, Read D, Taj U, et al
    Nudgeathons to control HIV: designing strategies using behavioural economics.
    AIDS. 2020;34:2337-2340.
    >> Share

  617. AVDOSHINA V, Mocchetti I
    HIV-associated neurodegenerative disorders: extracellular and intracellular mechanisms.
    AIDS. 2020;34:2334-2336.
    >> Share

  618. ZHAO T
    HIV-associated neurodegenerative disorders: role of endoplasmic reticulum in Gp120-mediated neurotoxicity.
    AIDS. 2020;34:2333-2334.
    >> Share

  619. VINIKOOR MJ, Hachaambwa L
    Advanced HIV disease during the 'Treat All' era in Botswana.
    AIDS. 2020;34:2321-2323.
    >> Share

  620. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    AIDS. 2020;34:2295-2304.
    >> Share

  621. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.
    AIDS. 2020;34:2201-2210.
    >> Share

  622. ABRAHAMS N, Mhlongo S, Dunkle K, Chirwa E, et al
    Increase in HIV incidence in women exposed to rape: a comparative cohort study.
    AIDS. 2020 Dec 1. doi: 10.1097/QAD.0000000000002779.
    >> Share

  623. WOOD BR
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
    AIDS. 2020;34:2319-2320.
    >> Share

    November 2020
  624. MARTY L, Lemsalu L, Kivite-Urtane A, Costagliola D, et al
    Revealing HIV epidemic dynamics and contrasting responses in two WHO Eastern European countries: insights from modeling and data triangulation.
    AIDS. 2020 Nov 30. doi: 10.1097/QAD.0000000000002778.
    >> Share

  625. SEYEDALINAGHI S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, et al
    HIV in Iran: onset, responses and future directions.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002757.
    >> Share

  626. XIA Y, Milwid RM, Godin A, Boily MC, et al
    Accuracy of self-reported HIV testing history and awareness of HIV-positive status among people living with HIV in four Sub-Saharan African countries.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002759.
    >> Share

  627. SUNDERMANN EE, Fields A, Saloner R, Gouaux B, et al
    The utility of olfactory function in distinguishing early stage Alzheimer's disease from HIV-associated neurocognitive disorder.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002761.
    >> Share

  628. MCFALL AM, Lau B, Latkin C, Srikrishnan AK, et al
    Optimizing respondent driven sampling to find undiagnosed HIV-infected people who inject drugs.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002763.
    >> Share

  629. ROSEBUSH JC, Best BM, Chadwick EG, Butler K, et al
    Pharmacokinetics and safety of maraviroc in neonates.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002762.
    >> Share

  630. TREVILLYAN JM, Dart A, Paul E, Cavassini M, et al
    Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk; a randomised, controlled trial.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002764.
    >> Share

  631. DESMONDE S, Ciaranello AL, Malateste K, Musick B, et al
    Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002765.
    >> Share

  632. HUAMAN MA, Juchnowski SM, Zidar DA, Kityo CM, et al
    Monocyte activation in persons living with HIV and tuberculosis coinfection.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002766.
    >> Share

  633. BROOKS KM, Momper JD, Pinilla M, Stek AM, et al
    Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002767.
    >> Share

  634. COOLEY SA, Paul RH, Strain JF, Boerwinkle A, et al
    Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002768.
    >> Share

  635. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Maintenance of statin therapy among people living with HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002769.
    >> Share

  636. GROENE EA, Valeris-Chacin RJ, Stadelman AM, Safo SE, et al
    Maternal HIV and child anthropometric outcomes over time: An analysis of Zimbabwe demographic health surveys from 2005-2015.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002772.
    >> Share

  637. BAKER JV, Wolfson J, Collins G, Morse C, et al
    Losartan to reduce inflammation and fibrosis endpoints in HIV disease (LIFE-HIV): results from a randomized placebo-controlled trial.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002773.
    >> Share

  638. ZEZIULIN O, Mollan KR, Shook-Sa BE, Hanscom B, et al
    Depressive symptoms and use of HIV care and medication-assisted treatment among people living with HIV who inject drugs.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002774.
    >> Share

  639. TSHIKUNG ON, Smit M, Marinosci A, Buvelot H, et al
    Caring for people living with HIV during the global COVID-19 pandemic.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002775.
    >> Share

  640. GARCIA M, Morcilla V, Navarrete-Munoz MA, Fisher K, et al
    HIV-DNA Content in pTfh Cells is Associated with Residual Viremia in Elite Controllers.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002776.
    >> Share

  641. VELLOZA J, Kapogiannis B, Bekker LG, Celum C, et al
    Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services?
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002777.
    >> Share

  642. ERLANDSON KM, Wu K, Lake JE, Samuels DC, et al
    Mitochondrial DNA haplogroups and weight gain following switch to INSTI-Based ART.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002771.
    >> Share

  643. HUGHES K, Chang J, Stadtler H, Wyatt C, et al
    HIV-1 infection of the kidney: mechanisms and implications.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002753.
    >> Share

  644. CHOW FC, Ma Y, Manion M, Rupert A, et al
    Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002755.
    >> Share

  645. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases Consensus panel: Erratum.
    AIDS. 2020;34:2161-2163.
    >> Share

  646. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.
    AIDS. 2020;34:2159.
    >> Share

  647. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.
    >> Share

  648. SOUDEYNS H, Dumond J
    Unexpectedly low levels of transplacental transfer of second-generation integrase strand transfer inhibitors bictegravir and cabotegravir.
    AIDS. 2020;34:2137-2139.
    >> Share

  649. LEVY JA, Coutinho RA, Saag MS
    AIDS new editor announcement.
    AIDS. 2020;34:1995.
    >> Share

  650. FARR ZUEND C, Noel-Romas L, Hoger S, Mccorriser S, et al
    Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002751.
    >> Share

  651. BEDIMO RJ, Park LS, Shebl F, Sigel K, et al
    Statin exposure and risk of cancer in people with and without HIV infection.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002748.
    >> Share

  652. SEVERIN D, Faiza B, Nadia M, Aurelie DT, et al
    Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002744.
    >> Share

  653. ADAMS JW, Khan MR, Bessey SE, Friedman SR, et al
    Pre-exposure prophylaxis (PrEP) strategies for African American Women Affected by Mass Incarceration: A Modeling Study.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002749.
    >> Share

  654. REIN SM, Lampe FC, Johnson MA, Bhagani S, et al
    All-cause hospitalisation according to demographic group in people living with HIV in the current ART era: Recent findings from a cohort study in the UK.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002750.
    >> Share

  655. NICHOLS BE, Cele R, Jamieson L, Long LC, et al
    Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002737.
    >> Share

  656. COLLINS LF, Colasanti JA, Nguyen ML, Moran CA, et al
    The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002746.
    >> Share

  657. PASVOL TJ, Teh J, Balfoussia D, Hall R, et al
    Outcomes of fertility investigations in a cohort of adults with perinatally acquired HIV-1 infection: a UK cross-sectional observational study.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002745.
    >> Share

  658. TAGO A, McKinnon LR, Wanjiru T, Muriuki F, et al
    Declines in HIV prevalence in female sex workers (FSWs) accessing an HIV treatment and prevention programme in Nairobi, Kenya over a 10-year period.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002747.
    >> Share

  659. Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study: Erratum.
    AIDS. 2020;34:1993.
    >> Share

  660. GREEN M
    A letter to a young HIV doctor.
    AIDS. 2020;34:1991-1992.
    >> Share

  661. GABUZDA D, McArthur JC, Letendre SL
    Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system.
    AIDS. 2020;34:1975-1977.
    >> Share

  662. PYRA M, Rusie L, Castro M, Keglovitz Baker K, et al
    A taxonomy of pragmatic measures of HIV preexposure prophylaxis use.
    AIDS. 2020;34:1951-1957.
    >> Share

  663. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020;34:1915-1921.
    >> Share

  664. LO B
    Toward respectful research with Indigenous people.
    AIDS. 2020;34:1979-1981.
    >> Share

  665. ROELOFSEN EE, Wildenbeest S, Mollema FP, Burger DM, et al
    Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomy.
    AIDS. 2020;34:1989-1991.
    >> Share

    October 2020
  666. SUGAWARA S, Manickam C, Reeves RK
    TRIGGERED: could refocused cell signaling be key to NK cell-based HIV immunotherapeutics?
    AIDS. 2020 Oct 27. doi: 10.1097/QAD.0000000000002743.
    >> Share

  667. SHERMAN BT, Hu X, Singh K, Haine L, et al
    Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002738.
    >> Share

  668. CHANDIWANA NC, Chersich M, Venter WF, Akpomiemie G, et al
    Unexpected interactions between dolutegravir and folate: randomised trial evidence from South Africa.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002741.
    >> Share

  669. CHLOE O, Elion R, Thompson M, Rockstroh JK, et al
    Changes in weight and body mass index with first-line doravirine-based therapy: a pooled analysis of three randomized controlled trials.
    AIDS. 2020 Oct 13. doi: 10.1097/QAD.0000000000002725.
    >> Share

  670. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002730.
    >> Share

  671. TEMU TM, Zifodya JS, Polyak SJ, Wagoner J, et al
    Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002729.
    >> Share

  672. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    >> Share

  673. WHITEMAN A, Baugher A, Sionean C
    Assessing self-reported discrimination among men who have sex with men.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002711.
    >> Share

  674. LU D, Sun H, Yu J, Kuang YQ, et al
    Chemsex drugs regulate HIV infection and replication in immune cells: A vicious circle.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002708.
    >> Share

  675. KOHLI M, Moore DJ, Moore RC
    Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002726.
    >> Share

  676. GILMORE JC, Serghides L, Bendayan R
    Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002707.
    >> Share

  677. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    >> Share

  678. ROURKE SB, Bekele T, Rachlis A, Kovacs C, et al
    Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002709.
    >> Share

  679. AUDET CM, Ngobeni S, Mkansi M, Wafawanaka F, et al
    An unrecognized key population? traditional treatment practices associated with HIV risk among traditional healers in rural South Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002710.
    >> Share

  680. SHANGANI S, Bhaskar N, Richmond N, Operario D, et al
    A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002713.
    >> Share

  681. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of pre-exposure prophylaxis in the Netherlands - a mixed-methods analysis.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002714.
    >> Share

  682. SIBIUDE J, Le Chenadec J, Mandelbrot L, Dollfus C, et al
    Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002719.
    >> Share

  683. NJUGUNA IN, Wagner AD, Neary J, Omondi VO, et al
    Financial incentives to increase pediatric hiv testing: a randomized trial.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002720.
    >> Share

  684. CARLANDER C, Wagner P, Yilmaz A, Sparen P, et al
    Employment by HIV status, mode of HIV transmission and migrant status: a nation-wide population-based study with twenty years of follow-up.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002724.
    >> Share

  685. SHANAUBE K, Schaap A, Hoddinott G, Mubekapi-Musadaidzwa C, et al
    Impact of a community-wide combination HIV prevention intervention on knowledge of HIV status among adolescents.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002722.
    >> Share

  686. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Incident Type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002718.
    >> Share

  687. JONES CI, Rose SL, Shutt A, Cairo C, et al
    Maternal HIV status skews transcriptomic response in infant cord blood monocytes exposed to BCG.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002706.
    >> Share

  688. ZHANG J, Thakuri BKC, Zhao J, Nguyen LN, et al
    LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002700.
    >> Share

  689. HESSOL NA, Barrett BW, Margolick JB, Plankey M, et al
    Risk of smoking-related cancers among women and men living with and without hiv.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002717.
    >> Share

  690. WAGMAN JA, Wynn A, Matsuzaki M, Gnatienko N, et al
    Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002716.
    >> Share

  691. VONASEK B, Kay A, Devezin T, Bacha JM, et al
    Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002715.
    >> Share

  692. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a gag mutation that abrogates KIR binding and disinhibits NK cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002721.
    >> Share

  693. PILKINGTON V, Hughes SL, Pepperrell T, McCann K, et al
    Tenofovir alafenamide versus tenofovir disoproxil fumarate - an updated meta-analysis of 14,894 patients across 14 trials.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002699.
    >> Share

  694. MURAKOSHI H, Chikata T, Akahoshi T, Zou C, et al
    Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002704.
    >> Share

  695. SERRANO PA, Daubert E, Munoz A, Hosek SG, et al
    Effect of Truvada lawsuit advertising on PrEP attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002728.
    >> Share

  696. GRANT M
    Regulation of natural killer cells: analog peptide handshake goes digital.
    AIDS. 2020;34:1857-1858.
    >> Share

  697. EL-SADR WM
    What one pandemic can teach us in facing another.
    AIDS. 2020;34:1757-1759.
    >> Share

    September 2020
  698. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002697.
    >> Share

  699. LEVY JA
    The need to reassess our approaches at HIV cure and prevention.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002695.
    >> Share

  700. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002692.
    >> Share

  701. CHIAO E, Lensing SY, Wiley DJ, Deshmukh AA, et al
    Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002694.
    >> Share

  702. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.
    >> Share

  703. BANDA FM, Powis KM, Sun S, Makhema J, et al
    Fetal biometry following in utero exposure to dolutegravir- or efavirenz-based antiretroviral therapy.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002674.
    >> Share

  704. SEELEY J, Blanc AK
    Reducing stigma and discrimination: new evidence and its implications.
    AIDS. 2020;34 Suppl 1:S1-S4.
    >> Share

    June 2020
  705. YADAVA SK, Vyas V, Jain H, Fazili T, et al
    Thrombotic thrombocytopenic purpura associated with AIDS: challenges in diagnosis and management.
    AIDS. 2020;34:1101-1102.
    >> Share

  706. ASHIGBIE PG, Laing RO, Wirtz VJ, Nkrumah N, et al
    Registration timelines of antiretroviral medicines in Ghana and Kenya.
    AIDS. 2020;34:1093-1095.
    >> Share

    March 2020
  707. ALAEI K, Zaidi H
    A centralized or decentralized approach when it comes to socially stigmatized health concerns in conservative social settings.
    AIDS. 2020;34:647-649.
    >> Share

  708. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.
    >> Share

    In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.
    AIDS. 2020;34:487.
    >> Share

    February 2020
  710. LIN KS, Win S, Nyein PP
    Drug-induced immune hemolytic anemia because of efavirenz: a case report.
    AIDS. 2020;34:326-328.
    >> Share

    December 2019
  711. CARR M, Richardson R, Tong W, Bloch M, et al
    Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002473.
    >> Share

    September 2019
  712. LAPADULA G, Bernasconi DP, Bai F, Foca E, et al
    Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances: Results from a randomized controlled trial.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002377.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016